+关注
PCQ
暂无个人介绍
IP属地:未知
21
关注
3
粉丝
0
主题
0
勋章
主贴
热门
PCQ
2021-12-23
[Smile]
昨夜今晨:美股指两连涨!特斯拉大涨超7%
PCQ
2021-12-16
[Smile] [Smile]
Rebound Anticipated For Singapore Stock Market<blockquote>新加坡股市有望反弹</blockquote>
PCQ
2021-12-11
[What]
Vaccine stocks dropped in morning trading<blockquote>疫苗股早盘交易中下跌</blockquote>
PCQ
2021-12-08
[Grin]
Apple shares rose more than 3% to a new high<blockquote>苹果股价上涨逾3%创新高</blockquote>
PCQ
2021-12-07
okay
Grab shares slid more than 4% in premarket trading<blockquote>Grab 股价在盘前交易中下跌超过 4%</blockquote>
PCQ
2021-12-05
[Sad]
Stocks gain on Friday to close out volatile week triggered by omicron fears<blockquote>周五股市上涨,结束了因奥密克戎担忧引发的动荡一周</blockquote>
PCQ
2021-12-02
[Smile]
Apple shares rose nearly 2% to a new high<blockquote>苹果股价上涨近2%创新高</blockquote>
PCQ
2021-12-01
Okay
Oversold Singapore Bourse Called Lower Again<blockquote>超卖新加坡证券交易所再次走低</blockquote>
PCQ
2021-11-29
okay
抱歉,原内容已删除
PCQ
2021-11-23
interesting
Can Apple Close Above The All-Time Highs This Week? Option Analysis<blockquote>苹果本周能否收于历史高点之上?期权分析</blockquote>
PCQ
2021-11-23
Okay
抱歉,原内容已删除
PCQ
2021-11-22
Okay
抱歉,原内容已删除
PCQ
2021-11-19
[Smile]
抱歉,原内容已删除
PCQ
2021-11-18
Okay
抱歉,原内容已删除
PCQ
2021-11-17
okay
抱歉,原内容已删除
PCQ
2021-11-15
Okay!
抱歉,原内容已删除
PCQ
2021-11-13
interesting
抱歉,原内容已删除
PCQ
2021-11-12
Okay nice
抱歉,原内容已删除
PCQ
2021-11-10
okay
抱歉,原内容已删除
PCQ
2021-11-09
Okay
Buffett Signals Caution With Berkshire on Stock-Selling Streak<blockquote>巴菲特对伯克希尔哈撒韦公司连续抛售股票表示谨慎</blockquote>
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4087463284623270","uuid":"4087463284623270","gmtCreate":1624360404939,"gmtModify":1637631494654,"name":"PCQ","pinyin":"pcq","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":21,"tweetSize":39,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.03","exceedPercentage":"60.48%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":691559816,"gmtCreate":1640223175185,"gmtModify":1640223175185,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691559816","repostId":"1183786099","repostType":2,"repost":{"id":"1183786099","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据,旨在帮助投资者理解世界,做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640217398,"share":"https://www.laohunote.com/m/news/1183786099?lang=zh_CN&edition=full","pubTime":"2021-12-23 07:56","market":"us","language":"zh","title":"昨夜今晨:美股指两连涨!特斯拉大涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1183786099","media":"老虎资讯综合","summary":"摘要:①纳指涨1.18%,新能源汽车股表现强势,特斯拉大涨7.5%;\n\n\n ②美国三季度实际GDP年化季环比终值 2.3%,较二季度增速大幅放缓;\n\n\n ③供应链称苹果首款电动车Apple Car将于","content":"<blockquote>\n 摘要:①纳指涨1.18%,新能源汽车股表现强势,特斯拉大涨7.5%;\n</blockquote>\n<blockquote>\n ②美国三季度实际GDP年化季环比终值 2.3%,较二季度增速大幅放缓;\n</blockquote>\n<blockquote>\n ③供应链称苹果首款电动车Apple Car将于明年9月发布。\n</blockquote>\n<p></p>\n<p><b>海外市场</b></p>\n<p>1、美股指两连涨!纳指涨超1% 特斯拉大涨7.5%</p>\n<p>美股三大指数集体收涨,主要股指连续第二个交易日反弹。美国总统拜登督促民众接种加强针,并表示不会恢复疫情爆发初期实施的严格封锁措施。美国第三季度GDP增长2.3%,好于市场预期。截至收盘,纳斯达克指数涨1.18%,标普500指数涨1.02%,道琼斯指数涨0.74%。</p>\n<p>新能源汽车股表现强势,SonoGroup涨近14%;特斯拉收涨7.5%,创11月1日以来最大单日涨幅,市值当日暴增706.21亿美元(约合人民币4498亿元)。</p>\n<p>小鹏汽车涨超4%,理想汽车涨1.4%。大型科技股集体走高,苹果涨1.53%,亚马逊涨0.36%,Meta跌1.12%,谷歌涨2.05%,微软涨1.81%,奈飞涨1.54%。</p>\n<p>2、热门中概股多数收跌 阿里跌超4%</p>\n<p>阿里巴巴跌超4%,此前阿里云被暂停作为工信部网络安全威胁信息共享平台合作单位</p>\n<p>其他中概股方面,雾芯科技涨超2%,京东微涨;贝壳收平,百度跌近1%,金山云、新东方跌超1%,滴滴跌超6%,好未来跌超3%,搜狐跌超2%。</p>\n<p>3、欧股主要指数上涨,法国CAC40指数涨超1%</p>\n<p>德国DAX30指数收涨0.91%,英国富时100指数涨0.60%,法国CAC40指数涨1.24%,欧洲斯托克50指数涨1.00%。</p>\n<p>4、原油库存降幅超预期 美油收高2.3%</p>\n<p>因美国能源信息署(EIA)报告称美国原油库存降幅超出预期,令油价得到支撑。最终,纽约商品交易所2月交割的西德克萨斯中质原油(WTI)期货价格上涨1.64美元,涨幅为2.3%,收于每桶72.76美元。</p>\n<p>5、黄金期货收高0.8% 站上1800美元关口</p>\n<p>最近黄金期货多次测试1800美元关口,但未能长时间维持在其上方。但在周三,美元走软和美国国债收益率低迷,帮助金价站上这一关口。</p>\n<p>最终,纽约商品交易所2月交割的黄金期货价格上涨13.50美元,涨幅为0.8%,收于每盎司1802.20美元。</p>\n<p>6、土耳其股市连续4个交易日收跌 22日触发一次熔断</p>\n<p>当地时间22日,土耳其伊斯坦布尔100指数开盘报1.832.14点,较前一日收盘下跌3.14%。当地时间14时39分,股指下跌超5%,触发熔断。随后股指持续震荡,当天收盘时跌幅为4.64%。这是土耳其股市连续第四个交易日收跌。</p>\n<p>分析人士指出,土耳其财政和货币政策的不可预测性,让投资者信心受到影响,在这种情况下,很多投资者可能会选择撤离观望。</p>\n<p>由于总统埃尔多安推动货币宽松政策,土耳其央行9月以来已经累计下调基准利率500个基点,而每次下调都使得里拉进一步贬值,和年初相比,里拉跌幅曾一度超过55%。</p>\n<p><b>国际宏观</b></p>\n<p>1、拜登声称假日季供应链危机已避免 呼吁通过重建更美好未来法案</p>\n<p>美国总统乔·拜登表示,他的政府与工会和企业一起成功避免了假日季节的供应链危机。</p>\n<p>“今年秋天的时候,我们听到很多关于供应链问题的可怕警告,声称假日前后会出现危机,”拜登在白宫说。 “所以我们采取了行动。我们召集了商界和劳工界的领袖来解决问题。这场被预测很可能发生的危机并未出现。”</p>\n<p>2、美国三季度实际GDP年化季环比终值 2.3%,较二季度增速大幅放缓</p>\n<p>美国三季度实际GDP年化季环比终值 2.3%,预期 2.1%,前值 2.1%,是自2020年第二季度以来的最低增速。三季度增长放缓主要是由于全球供应链紧张导致供应短缺,以及政府向企业、家庭、和地方政府提供的疫情支持资金减少。</p>\n<p>3、美国三季度核心PCE物价指数创近30年新高 符合预期</p>\n<p>12月22日周三,据美国商务部统计,美国第三季度核心PCE物价指数年化季环比终值上涨4.6%,略高于4.5%的前值和预期;同比终值上升3.6%,与预期持平,仍是近30年最高水平。</p>\n<p>4、今年美国IPO发行量创下历史纪录 但回报率差强人意</p>\n<p>根据彭博汇编的数据,今年481宗美国IPO中有一半以上的交易价格低于发行价。这些交易,不包括更多的特殊目的收购公司,总共创下了约1670亿美元的记录,轻松超越2020年。</p>\n<p>尽管发行金额创下历史新高,但由于波动性和表现不佳,对IPO的热情在年底有所减弱。交易商表示,尽管2022年第一季看起来将十分忙录,但预计未来一年会较为波动。</p>\n<p>5、美国11月二手房销量连续第三个月增长</p>\n<p>美国全国地产经纪商协会周三公布的数据显示,11月二手房销量环比增长1.9%,折合年率达646万套,创下1月以来最大增幅。彭博调查预估中值为6.53万套。</p>\n<p>该数据表明住房需求正在加速上升,尤其是在高端市场,因为贷款成本仍远低于新冠疫情前的水平。即便如此,高房价也可能使一些潜在买家望而却步,尤其是收入水平较低、受通胀打击更大的消费者。</p>\n<p>6、美国12月消费者信心指数上升 克服了Omicron带来的恐慌</p>\n<p>世界大型企业研究会周三的报告显示,消费者信心指数升至115.8,11月数据被向上修正为111.9。接受彭博调查的经济学家预期为111。</p>\n<p>数据显示,尽管随着omicron的传播,美国一些地区实施了新的防疫限制措施,但消费者心态仍乐观。美联储主席鲍威尔和多位经济学家表示,随着美国人对新冠病毒及其变异株的适应性增强,每一波疫情带来的经济影响会变得较小。</p>\n<p>7、世卫组织正在确定第二代新冠疫苗</p>\n<p>世卫组织总干事谭德塞在22日的新闻发布会上透露,世卫组织正在通过疫苗“团结试验”确定第二代新冠疫苗。</p>\n<p>谭德塞表示,相关研究团队于9月下旬开始招募志愿者,到目前为止,已有超过11500人参加了试验。截至目前,该试验包括两种疫苗,另外三种疫苗不久将被纳入,而且还可能纳入更多的疫苗。世卫组织邀请所有国家和研究中心参与这项试验。</p>\n<p>8、美国政府宣布将学生贷款偿还期限延至明年5月1日</p>\n<p>当地时间22日,美国白宫新闻秘书珍·普萨基在简报会上证实,拜登已经宣布将学生贷款的偿还期限延长90天,到明年的5月1日。普萨基说,部分学生贷款的借款人受到新冠肺炎疫情的影响,需要时间偿还。</p>\n<p>9、欧洲能源告急!天然气狂飙新高 英国企业称正处国家危机 意大利总理高呼需紧急行动</p>\n<p>天然气暴涨也让欧洲国家坐不住了。本周三,意大利总理德拉吉在年末新闻发布会上表示,遏制能源短缺亟需采取紧急政策行动:“能源价格上涨需要紧急行动,我们不能等了。”</p>\n<p>同在周三,英国能源企业和业界组织也对今年冬季的能源危机发出警告。媒体称,英国的议员感到恐慌,可能为保护国内家庭而寻求设定电费上限。</p>\n<p>10、联合国安理会投票通过为阿富汗提供人道援助的决议</p>\n<p>当地时间22日,联合国安理会一致通过决议,向处于经济崩溃边缘的阿富汗提供人道主义援助。中国常驻联合国代表张军表示,中方支持联合国发挥更大协调作用,呼吁所有国际伙伴加大对阿援助力度,并解除对阿制裁。</p>\n<p><b>公司新闻</b></p>\n<p>1、<a href=\"https://laohu8.com/NW/2193115827\" target=\"_blank\">特斯拉股价一度大涨逾8% 市值重返1万亿美元上方</a></p>\n<p>特斯拉股价周三一度大涨逾8%,助其市值重返1万亿美元上方,此前该公司CEO埃隆•马斯克在接受采访时透露,他已完成了出售10%所持特斯拉股票的目标。</p>\n<p>Wedbush分析师Dan Ives评价道,在经历了几周的黑暗后,特斯拉终于迎来了好消息,马斯克的这一声明消除了对特斯拉股价的威胁,抛售压力和负面看法问题已经解决,投资者重新关注华尔街的基本面驱动因素。</p>\n<p>2、<a href=\"https://laohu8.com/NW/2193116621\" target=\"_blank\">苹果汽车早产!供应链称Apple Car将于明年9月发布</a></p>\n<p>12月2日消息,有媒体报道称,苹果首款电动车「Apple Car」有望将提前问世。此前,外界原本预期苹果至少要到 2023 年才会推出 Apple Car。不过,国内供应链大厂董座直言,苹果正准备在明年 9 月推出 Apple Car。某电动车供应链大厂高层透露,随着订单出货、组装完成,Apple Car 首款原型车,已有数十辆秘密在美国加州上路测试中,预计出货量与商机将会在明年初显,2022 年全面爆发。</p>\n<p>3、<a href=\"https://laohu8.com/NW/2193172113\" target=\"_blank\">辉瑞新冠口服药获美国FDA紧急授权</a></p>\n<p>当地时间22日,辉瑞公司生产的抗新冠病毒口服药PAXLOVID获得了美国食品药品监督管理局的紧急使用授权,可以用于治疗出现轻度至中度症状的新冠肺炎患者。</p>\n<p>4、<a href=\"https://laohu8.com/NW/2193118492\" target=\"_blank\">美国联邦贸易委员会对亚马逊云计算业务展开新的反垄断调查</a></p>\n<p>知情人士透露,美国联邦贸易委员会(FTC)正在推进对亚马逊云计算业务的反垄断调查。</p>\n<p>FTC主席Lina Khan一直是亚马逊的批评者,正在推进前任主席几年前启动的一项调查。</p>\n<p>亚马逊160亿美元的云计算业务也是该公司最大的利润源。调查这项业务之际,Khan早已把目标瞄准了美国一些最大的科技公司。Khan曾是哥伦比亚大学法学院教授,在反垄断界大名鼎鼎,一直警告亚马逊之类公司对数字经济时代的竞争构成威胁。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>昨夜今晨:美股指两连涨!特斯拉大涨超7%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n昨夜今晨:美股指两连涨!特斯拉大涨超7%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-12-23 07:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n 摘要:①纳指涨1.18%,新能源汽车股表现强势,特斯拉大涨7.5%;\n</blockquote>\n<blockquote>\n ②美国三季度实际GDP年化季环比终值 2.3%,较二季度增速大幅放缓;\n</blockquote>\n<blockquote>\n ③供应链称苹果首款电动车Apple Car将于明年9月发布。\n</blockquote>\n<p></p>\n<p><b>海外市场</b></p>\n<p>1、美股指两连涨!纳指涨超1% 特斯拉大涨7.5%</p>\n<p>美股三大指数集体收涨,主要股指连续第二个交易日反弹。美国总统拜登督促民众接种加强针,并表示不会恢复疫情爆发初期实施的严格封锁措施。美国第三季度GDP增长2.3%,好于市场预期。截至收盘,纳斯达克指数涨1.18%,标普500指数涨1.02%,道琼斯指数涨0.74%。</p>\n<p>新能源汽车股表现强势,SonoGroup涨近14%;特斯拉收涨7.5%,创11月1日以来最大单日涨幅,市值当日暴增706.21亿美元(约合人民币4498亿元)。</p>\n<p>小鹏汽车涨超4%,理想汽车涨1.4%。大型科技股集体走高,苹果涨1.53%,亚马逊涨0.36%,Meta跌1.12%,谷歌涨2.05%,微软涨1.81%,奈飞涨1.54%。</p>\n<p>2、热门中概股多数收跌 阿里跌超4%</p>\n<p>阿里巴巴跌超4%,此前阿里云被暂停作为工信部网络安全威胁信息共享平台合作单位</p>\n<p>其他中概股方面,雾芯科技涨超2%,京东微涨;贝壳收平,百度跌近1%,金山云、新东方跌超1%,滴滴跌超6%,好未来跌超3%,搜狐跌超2%。</p>\n<p>3、欧股主要指数上涨,法国CAC40指数涨超1%</p>\n<p>德国DAX30指数收涨0.91%,英国富时100指数涨0.60%,法国CAC40指数涨1.24%,欧洲斯托克50指数涨1.00%。</p>\n<p>4、原油库存降幅超预期 美油收高2.3%</p>\n<p>因美国能源信息署(EIA)报告称美国原油库存降幅超出预期,令油价得到支撑。最终,纽约商品交易所2月交割的西德克萨斯中质原油(WTI)期货价格上涨1.64美元,涨幅为2.3%,收于每桶72.76美元。</p>\n<p>5、黄金期货收高0.8% 站上1800美元关口</p>\n<p>最近黄金期货多次测试1800美元关口,但未能长时间维持在其上方。但在周三,美元走软和美国国债收益率低迷,帮助金价站上这一关口。</p>\n<p>最终,纽约商品交易所2月交割的黄金期货价格上涨13.50美元,涨幅为0.8%,收于每盎司1802.20美元。</p>\n<p>6、土耳其股市连续4个交易日收跌 22日触发一次熔断</p>\n<p>当地时间22日,土耳其伊斯坦布尔100指数开盘报1.832.14点,较前一日收盘下跌3.14%。当地时间14时39分,股指下跌超5%,触发熔断。随后股指持续震荡,当天收盘时跌幅为4.64%。这是土耳其股市连续第四个交易日收跌。</p>\n<p>分析人士指出,土耳其财政和货币政策的不可预测性,让投资者信心受到影响,在这种情况下,很多投资者可能会选择撤离观望。</p>\n<p>由于总统埃尔多安推动货币宽松政策,土耳其央行9月以来已经累计下调基准利率500个基点,而每次下调都使得里拉进一步贬值,和年初相比,里拉跌幅曾一度超过55%。</p>\n<p><b>国际宏观</b></p>\n<p>1、拜登声称假日季供应链危机已避免 呼吁通过重建更美好未来法案</p>\n<p>美国总统乔·拜登表示,他的政府与工会和企业一起成功避免了假日季节的供应链危机。</p>\n<p>“今年秋天的时候,我们听到很多关于供应链问题的可怕警告,声称假日前后会出现危机,”拜登在白宫说。 “所以我们采取了行动。我们召集了商界和劳工界的领袖来解决问题。这场被预测很可能发生的危机并未出现。”</p>\n<p>2、美国三季度实际GDP年化季环比终值 2.3%,较二季度增速大幅放缓</p>\n<p>美国三季度实际GDP年化季环比终值 2.3%,预期 2.1%,前值 2.1%,是自2020年第二季度以来的最低增速。三季度增长放缓主要是由于全球供应链紧张导致供应短缺,以及政府向企业、家庭、和地方政府提供的疫情支持资金减少。</p>\n<p>3、美国三季度核心PCE物价指数创近30年新高 符合预期</p>\n<p>12月22日周三,据美国商务部统计,美国第三季度核心PCE物价指数年化季环比终值上涨4.6%,略高于4.5%的前值和预期;同比终值上升3.6%,与预期持平,仍是近30年最高水平。</p>\n<p>4、今年美国IPO发行量创下历史纪录 但回报率差强人意</p>\n<p>根据彭博汇编的数据,今年481宗美国IPO中有一半以上的交易价格低于发行价。这些交易,不包括更多的特殊目的收购公司,总共创下了约1670亿美元的记录,轻松超越2020年。</p>\n<p>尽管发行金额创下历史新高,但由于波动性和表现不佳,对IPO的热情在年底有所减弱。交易商表示,尽管2022年第一季看起来将十分忙录,但预计未来一年会较为波动。</p>\n<p>5、美国11月二手房销量连续第三个月增长</p>\n<p>美国全国地产经纪商协会周三公布的数据显示,11月二手房销量环比增长1.9%,折合年率达646万套,创下1月以来最大增幅。彭博调查预估中值为6.53万套。</p>\n<p>该数据表明住房需求正在加速上升,尤其是在高端市场,因为贷款成本仍远低于新冠疫情前的水平。即便如此,高房价也可能使一些潜在买家望而却步,尤其是收入水平较低、受通胀打击更大的消费者。</p>\n<p>6、美国12月消费者信心指数上升 克服了Omicron带来的恐慌</p>\n<p>世界大型企业研究会周三的报告显示,消费者信心指数升至115.8,11月数据被向上修正为111.9。接受彭博调查的经济学家预期为111。</p>\n<p>数据显示,尽管随着omicron的传播,美国一些地区实施了新的防疫限制措施,但消费者心态仍乐观。美联储主席鲍威尔和多位经济学家表示,随着美国人对新冠病毒及其变异株的适应性增强,每一波疫情带来的经济影响会变得较小。</p>\n<p>7、世卫组织正在确定第二代新冠疫苗</p>\n<p>世卫组织总干事谭德塞在22日的新闻发布会上透露,世卫组织正在通过疫苗“团结试验”确定第二代新冠疫苗。</p>\n<p>谭德塞表示,相关研究团队于9月下旬开始招募志愿者,到目前为止,已有超过11500人参加了试验。截至目前,该试验包括两种疫苗,另外三种疫苗不久将被纳入,而且还可能纳入更多的疫苗。世卫组织邀请所有国家和研究中心参与这项试验。</p>\n<p>8、美国政府宣布将学生贷款偿还期限延至明年5月1日</p>\n<p>当地时间22日,美国白宫新闻秘书珍·普萨基在简报会上证实,拜登已经宣布将学生贷款的偿还期限延长90天,到明年的5月1日。普萨基说,部分学生贷款的借款人受到新冠肺炎疫情的影响,需要时间偿还。</p>\n<p>9、欧洲能源告急!天然气狂飙新高 英国企业称正处国家危机 意大利总理高呼需紧急行动</p>\n<p>天然气暴涨也让欧洲国家坐不住了。本周三,意大利总理德拉吉在年末新闻发布会上表示,遏制能源短缺亟需采取紧急政策行动:“能源价格上涨需要紧急行动,我们不能等了。”</p>\n<p>同在周三,英国能源企业和业界组织也对今年冬季的能源危机发出警告。媒体称,英国的议员感到恐慌,可能为保护国内家庭而寻求设定电费上限。</p>\n<p>10、联合国安理会投票通过为阿富汗提供人道援助的决议</p>\n<p>当地时间22日,联合国安理会一致通过决议,向处于经济崩溃边缘的阿富汗提供人道主义援助。中国常驻联合国代表张军表示,中方支持联合国发挥更大协调作用,呼吁所有国际伙伴加大对阿援助力度,并解除对阿制裁。</p>\n<p><b>公司新闻</b></p>\n<p>1、<a href=\"https://laohu8.com/NW/2193115827\" target=\"_blank\">特斯拉股价一度大涨逾8% 市值重返1万亿美元上方</a></p>\n<p>特斯拉股价周三一度大涨逾8%,助其市值重返1万亿美元上方,此前该公司CEO埃隆•马斯克在接受采访时透露,他已完成了出售10%所持特斯拉股票的目标。</p>\n<p>Wedbush分析师Dan Ives评价道,在经历了几周的黑暗后,特斯拉终于迎来了好消息,马斯克的这一声明消除了对特斯拉股价的威胁,抛售压力和负面看法问题已经解决,投资者重新关注华尔街的基本面驱动因素。</p>\n<p>2、<a href=\"https://laohu8.com/NW/2193116621\" target=\"_blank\">苹果汽车早产!供应链称Apple Car将于明年9月发布</a></p>\n<p>12月2日消息,有媒体报道称,苹果首款电动车「Apple Car」有望将提前问世。此前,外界原本预期苹果至少要到 2023 年才会推出 Apple Car。不过,国内供应链大厂董座直言,苹果正准备在明年 9 月推出 Apple Car。某电动车供应链大厂高层透露,随着订单出货、组装完成,Apple Car 首款原型车,已有数十辆秘密在美国加州上路测试中,预计出货量与商机将会在明年初显,2022 年全面爆发。</p>\n<p>3、<a href=\"https://laohu8.com/NW/2193172113\" target=\"_blank\">辉瑞新冠口服药获美国FDA紧急授权</a></p>\n<p>当地时间22日,辉瑞公司生产的抗新冠病毒口服药PAXLOVID获得了美国食品药品监督管理局的紧急使用授权,可以用于治疗出现轻度至中度症状的新冠肺炎患者。</p>\n<p>4、<a href=\"https://laohu8.com/NW/2193118492\" target=\"_blank\">美国联邦贸易委员会对亚马逊云计算业务展开新的反垄断调查</a></p>\n<p>知情人士透露,美国联邦贸易委员会(FTC)正在推进对亚马逊云计算业务的反垄断调查。</p>\n<p>FTC主席Lina Khan一直是亚马逊的批评者,正在推进前任主席几年前启动的一项调查。</p>\n<p>亚马逊160亿美元的云计算业务也是该公司最大的利润源。调查这项业务之际,Khan早已把目标瞄准了美国一些最大的科技公司。Khan曾是哥伦比亚大学法学院教授,在反垄断界大名鼎鼎,一直警告亚马逊之类公司对数字经济时代的竞争构成威胁。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/b23574aac95526c9e5c62ebc8dd25130","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183786099","content_text":"摘要:①纳指涨1.18%,新能源汽车股表现强势,特斯拉大涨7.5%;\n\n\n ②美国三季度实际GDP年化季环比终值 2.3%,较二季度增速大幅放缓;\n\n\n ③供应链称苹果首款电动车Apple Car将于明年9月发布。\n\n\n海外市场\n1、美股指两连涨!纳指涨超1% 特斯拉大涨7.5%\n美股三大指数集体收涨,主要股指连续第二个交易日反弹。美国总统拜登督促民众接种加强针,并表示不会恢复疫情爆发初期实施的严格封锁措施。美国第三季度GDP增长2.3%,好于市场预期。截至收盘,纳斯达克指数涨1.18%,标普500指数涨1.02%,道琼斯指数涨0.74%。\n新能源汽车股表现强势,SonoGroup涨近14%;特斯拉收涨7.5%,创11月1日以来最大单日涨幅,市值当日暴增706.21亿美元(约合人民币4498亿元)。\n小鹏汽车涨超4%,理想汽车涨1.4%。大型科技股集体走高,苹果涨1.53%,亚马逊涨0.36%,Meta跌1.12%,谷歌涨2.05%,微软涨1.81%,奈飞涨1.54%。\n2、热门中概股多数收跌 阿里跌超4%\n阿里巴巴跌超4%,此前阿里云被暂停作为工信部网络安全威胁信息共享平台合作单位\n其他中概股方面,雾芯科技涨超2%,京东微涨;贝壳收平,百度跌近1%,金山云、新东方跌超1%,滴滴跌超6%,好未来跌超3%,搜狐跌超2%。\n3、欧股主要指数上涨,法国CAC40指数涨超1%\n德国DAX30指数收涨0.91%,英国富时100指数涨0.60%,法国CAC40指数涨1.24%,欧洲斯托克50指数涨1.00%。\n4、原油库存降幅超预期 美油收高2.3%\n因美国能源信息署(EIA)报告称美国原油库存降幅超出预期,令油价得到支撑。最终,纽约商品交易所2月交割的西德克萨斯中质原油(WTI)期货价格上涨1.64美元,涨幅为2.3%,收于每桶72.76美元。\n5、黄金期货收高0.8% 站上1800美元关口\n最近黄金期货多次测试1800美元关口,但未能长时间维持在其上方。但在周三,美元走软和美国国债收益率低迷,帮助金价站上这一关口。\n最终,纽约商品交易所2月交割的黄金期货价格上涨13.50美元,涨幅为0.8%,收于每盎司1802.20美元。\n6、土耳其股市连续4个交易日收跌 22日触发一次熔断\n当地时间22日,土耳其伊斯坦布尔100指数开盘报1.832.14点,较前一日收盘下跌3.14%。当地时间14时39分,股指下跌超5%,触发熔断。随后股指持续震荡,当天收盘时跌幅为4.64%。这是土耳其股市连续第四个交易日收跌。\n分析人士指出,土耳其财政和货币政策的不可预测性,让投资者信心受到影响,在这种情况下,很多投资者可能会选择撤离观望。\n由于总统埃尔多安推动货币宽松政策,土耳其央行9月以来已经累计下调基准利率500个基点,而每次下调都使得里拉进一步贬值,和年初相比,里拉跌幅曾一度超过55%。\n国际宏观\n1、拜登声称假日季供应链危机已避免 呼吁通过重建更美好未来法案\n美国总统乔·拜登表示,他的政府与工会和企业一起成功避免了假日季节的供应链危机。\n“今年秋天的时候,我们听到很多关于供应链问题的可怕警告,声称假日前后会出现危机,”拜登在白宫说。 “所以我们采取了行动。我们召集了商界和劳工界的领袖来解决问题。这场被预测很可能发生的危机并未出现。”\n2、美国三季度实际GDP年化季环比终值 2.3%,较二季度增速大幅放缓\n美国三季度实际GDP年化季环比终值 2.3%,预期 2.1%,前值 2.1%,是自2020年第二季度以来的最低增速。三季度增长放缓主要是由于全球供应链紧张导致供应短缺,以及政府向企业、家庭、和地方政府提供的疫情支持资金减少。\n3、美国三季度核心PCE物价指数创近30年新高 符合预期\n12月22日周三,据美国商务部统计,美国第三季度核心PCE物价指数年化季环比终值上涨4.6%,略高于4.5%的前值和预期;同比终值上升3.6%,与预期持平,仍是近30年最高水平。\n4、今年美国IPO发行量创下历史纪录 但回报率差强人意\n根据彭博汇编的数据,今年481宗美国IPO中有一半以上的交易价格低于发行价。这些交易,不包括更多的特殊目的收购公司,总共创下了约1670亿美元的记录,轻松超越2020年。\n尽管发行金额创下历史新高,但由于波动性和表现不佳,对IPO的热情在年底有所减弱。交易商表示,尽管2022年第一季看起来将十分忙录,但预计未来一年会较为波动。\n5、美国11月二手房销量连续第三个月增长\n美国全国地产经纪商协会周三公布的数据显示,11月二手房销量环比增长1.9%,折合年率达646万套,创下1月以来最大增幅。彭博调查预估中值为6.53万套。\n该数据表明住房需求正在加速上升,尤其是在高端市场,因为贷款成本仍远低于新冠疫情前的水平。即便如此,高房价也可能使一些潜在买家望而却步,尤其是收入水平较低、受通胀打击更大的消费者。\n6、美国12月消费者信心指数上升 克服了Omicron带来的恐慌\n世界大型企业研究会周三的报告显示,消费者信心指数升至115.8,11月数据被向上修正为111.9。接受彭博调查的经济学家预期为111。\n数据显示,尽管随着omicron的传播,美国一些地区实施了新的防疫限制措施,但消费者心态仍乐观。美联储主席鲍威尔和多位经济学家表示,随着美国人对新冠病毒及其变异株的适应性增强,每一波疫情带来的经济影响会变得较小。\n7、世卫组织正在确定第二代新冠疫苗\n世卫组织总干事谭德塞在22日的新闻发布会上透露,世卫组织正在通过疫苗“团结试验”确定第二代新冠疫苗。\n谭德塞表示,相关研究团队于9月下旬开始招募志愿者,到目前为止,已有超过11500人参加了试验。截至目前,该试验包括两种疫苗,另外三种疫苗不久将被纳入,而且还可能纳入更多的疫苗。世卫组织邀请所有国家和研究中心参与这项试验。\n8、美国政府宣布将学生贷款偿还期限延至明年5月1日\n当地时间22日,美国白宫新闻秘书珍·普萨基在简报会上证实,拜登已经宣布将学生贷款的偿还期限延长90天,到明年的5月1日。普萨基说,部分学生贷款的借款人受到新冠肺炎疫情的影响,需要时间偿还。\n9、欧洲能源告急!天然气狂飙新高 英国企业称正处国家危机 意大利总理高呼需紧急行动\n天然气暴涨也让欧洲国家坐不住了。本周三,意大利总理德拉吉在年末新闻发布会上表示,遏制能源短缺亟需采取紧急政策行动:“能源价格上涨需要紧急行动,我们不能等了。”\n同在周三,英国能源企业和业界组织也对今年冬季的能源危机发出警告。媒体称,英国的议员感到恐慌,可能为保护国内家庭而寻求设定电费上限。\n10、联合国安理会投票通过为阿富汗提供人道援助的决议\n当地时间22日,联合国安理会一致通过决议,向处于经济崩溃边缘的阿富汗提供人道主义援助。中国常驻联合国代表张军表示,中方支持联合国发挥更大协调作用,呼吁所有国际伙伴加大对阿援助力度,并解除对阿制裁。\n公司新闻\n1、特斯拉股价一度大涨逾8% 市值重返1万亿美元上方\n特斯拉股价周三一度大涨逾8%,助其市值重返1万亿美元上方,此前该公司CEO埃隆•马斯克在接受采访时透露,他已完成了出售10%所持特斯拉股票的目标。\nWedbush分析师Dan Ives评价道,在经历了几周的黑暗后,特斯拉终于迎来了好消息,马斯克的这一声明消除了对特斯拉股价的威胁,抛售压力和负面看法问题已经解决,投资者重新关注华尔街的基本面驱动因素。\n2、苹果汽车早产!供应链称Apple Car将于明年9月发布\n12月2日消息,有媒体报道称,苹果首款电动车「Apple Car」有望将提前问世。此前,外界原本预期苹果至少要到 2023 年才会推出 Apple Car。不过,国内供应链大厂董座直言,苹果正准备在明年 9 月推出 Apple Car。某电动车供应链大厂高层透露,随着订单出货、组装完成,Apple Car 首款原型车,已有数十辆秘密在美国加州上路测试中,预计出货量与商机将会在明年初显,2022 年全面爆发。\n3、辉瑞新冠口服药获美国FDA紧急授权\n当地时间22日,辉瑞公司生产的抗新冠病毒口服药PAXLOVID获得了美国食品药品监督管理局的紧急使用授权,可以用于治疗出现轻度至中度症状的新冠肺炎患者。\n4、美国联邦贸易委员会对亚马逊云计算业务展开新的反垄断调查\n知情人士透露,美国联邦贸易委员会(FTC)正在推进对亚马逊云计算业务的反垄断调查。\nFTC主席Lina Khan一直是亚马逊的批评者,正在推进前任主席几年前启动的一项调查。\n亚马逊160亿美元的云计算业务也是该公司最大的利润源。调查这项业务之际,Khan早已把目标瞄准了美国一些最大的科技公司。Khan曾是哥伦比亚大学法学院教授,在反垄断界大名鼎鼎,一直警告亚马逊之类公司对数字经济时代的竞争构成威胁。","news_type":1,"symbols_score_info":{".SPX":0.9,".DJI":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":5081,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690069678,"gmtCreate":1639614219904,"gmtModify":1639614219904,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"[Smile] [Smile] ","listText":"[Smile] [Smile] ","text":"[Smile] [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690069678","repostId":"1194155872","repostType":4,"repost":{"id":"1194155872","kind":"news","pubTimestamp":1639613035,"share":"https://www.laohunote.com/m/news/1194155872?lang=zh_CN&edition=full","pubTime":"2021-12-16 08:03","market":"us","language":"en","title":"Rebound Anticipated For Singapore Stock Market<blockquote>新加坡股市有望反弹</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1194155872","media":"RTTNews","summary":"The Singapore stock market headed south again on Wednesday, one session after ending the two-day sli","content":"<p>The Singapore stock market headed south again on Wednesday, one session after ending the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just beneath the 3,115-point plateau although it figures to bounce higher again on Thursday.</p><p><blockquote>新加坡股市周三再次走低,此前一个交易日结束了连续两天下跌超过20点或0.7%的下跌。海峡时报指数目前略低于 3,115 点的平台位,但预计周四将再次反弹。</blockquote></p><p> The global forecast for the Asian markets is upbeat following results of the FOMC's monetary policy meeting. The European and U.S. markets were solidly higher and the Asian bourses figure to open in similar fashion.</p><p><blockquote>FOMC货币政策会议结果公布后,亚洲市场的全球前景乐观。欧洲和美国市场稳步走高,亚洲股市也将以类似的方式开盘。</blockquote></p><p> The STI finished modestly lower on Wednesday following losses from the properties and industrials, while the financials were mixed.</p><p><blockquote>由于房地产和工业股下跌,STI 周三小幅收低,而金融股涨跌互现。</blockquote></p><p> For the day, the index slid 6.21 points or 0.20 percent to finish at 3,114.88 after trading between 3,106.63 and 3,120.55. Volume was 883.4 million shares worth 761.8 million Singapore dollars. There were 264 decliners and 180 gainers.</p><p><blockquote>当天,该指数在3,106.63至3,120.55之间交易后,下跌6.21点或0.20%,收于3,114.88点。成交量为8.834亿股,价值7.618亿新加坡元。下跌的有264家,上涨的有180家。</blockquote></p><p> Among the actives, Ascendas REIT lost 0.34 percent, while CapitaLand Integrated Commercial Trust retreated 0.50 percent, City Developments sank 0.42 percent, Comfort DelGro jumped 1.45 percent, Dairy Farm International plummeted 2.42 percent, DBS Group rose 0.19 percent, Genting Singapore surrendered 0.64 percent, Keppel Corp shed 0.39 percent, Mapletree Commercial Trust plunged 0.98 percent, Mapletree Logistics Trust declined 0.53 percent, Oversea-Chinese Banking Corporation fell 0.27 percent, SembCorp Industries skidded 0.51 percent, Singapore Airlines dipped 0.20 percent, Singapore Exchange slid 0.21 percent, SingTel dropped 0.41 percent, Thai Beverage tumbled 0.75 percent, United Overseas Bank collected 0.15 percent, Wilmar International tanked 0.96 percent and Yangzijiang Shipbuilding, Singapore Press Holdings, Singapore Technologies Engineering and SATS were unchanged.</p><p><blockquote>资产中,Ascendas REIT下跌0.34%,凯德综合商业信托下跌0.50%,City Developments下跌0.42%,Comfort DelGro上涨1.45%,Dairy Farm International暴跌2.42%,星展集团上涨0.19%,云顶新加坡投降0.64%,吉宝集团下跌0.39%,丰树商业信托暴跌0.98%,丰树物流信托下跌0.53%,华侨银行下跌0.27%,胜科实业下跌0.51%,新加坡航空下跌0.20%,新加坡交易所下跌0.21%,新加坡电信下跌0.41%,泰国饮料下跌0.75%,大华银行上涨0.15%,丰益国际下跌0.96%,扬子江造船、新加坡报业控股、新加坡</blockquote></p><p> The lead from Wall Street is broadly positive as the major averages opened slightly lower on Wednesday but then surged in the afternoon to finish sharply higher.</p><p><blockquote>华尔街的领先优势总体上是积极的,因为主要股指周三开盘小幅走低,但随后在下午飙升,收盘大幅走高。</blockquote></p><p> The Dow soared 383.25 points or 1.08 percent to finish at 35,927.43, while the NASDAQ spiked 327.94 points or 2.15 percent to end at 15,565.58 and the S&P 500 jumped 75.76 points or 1.63 percent to close at 4,709.85.</p><p><blockquote>道琼斯指数飙升383.25点或1.08%,收于35927.43点,而纳斯达克指数飙升327.94点或2.15%,收于15565.58点,标普500指数上涨75.76点或1.63%,收于4709.85点。</blockquote></p><p> The late-day rally on Wall Street came after the Fed announced its widely expected decision to accelerate the pace of reductions to its asset purchases program. Citing inflation developments and further improvement in the labor market, the Fed said it has decided to reduce the monthly pace of its net asset purchases by $30 billion per month, double the previously announced $15 billion per month.</p><p><blockquote>华尔街尾盘上涨之前,美联储宣布了人们普遍预期的加快资产购买计划削减步伐的决定。美联储以通胀发展和劳动力市场进一步改善为由表示,已决定将每月净资产购买速度降低 300 亿美元,是此前宣布的每月 150 亿美元的两倍。</blockquote></p><p> The Fed said it expects similar reductions in the pace of net asset purchases will likely be appropriate each month, pointing to an end to the program next March. Analysts partly attributed the subsequent rally to relief that the Fed was not more aggressive in accelerating the timetable for halting its asset purchases.</p><p><blockquote>美联储表示,预计每月净资产购买步伐的类似降低可能是合适的,这表明该计划将于明年 3 月结束。分析师将随后的反弹部分归因于美联储没有更积极地加快停止资产购买的时间表,这让人松了一口气。</blockquote></p><p> Meanwhile, the Fed also announced its widely expected decision to keep the target range for the federal funds rate at zero to 0.25 percent. The central bank's latest projections forecast as many three rate hikes in 2022 compared to the lone rate hike forecast in September.</p><p><blockquote>与此同时,美联储还宣布了广泛预期的决定,将联邦基金利率目标区间维持在零至0.25%。与 9 月份的唯一一次加息预测相比,央行最新预测 2022 年将加息三次。</blockquote></p><p> Despite the prospect of sooner than expected rate hikes, analysts suggested traders were pleased with the increased level of certainty provided by the Fed's latest projections.</p><p><blockquote>尽管加息前景早于预期,但分析师表示,交易员对美联储最新预测提供的确定性水平的提高感到满意。</blockquote></p><p> Crude oil futures settled higher on Wednesday after the Energy Information Administration (EIA) said crude inventories in the U.S. dropped by 4.6 million barrels last week. West Texas Intermediate crude oil futures for January ended up by $0.14 or 0.2 percent at $70.87 a barrel.</p><p><blockquote>美国能源信息署 (EIA) 表示上周美国原油库存下降 460 万桶后,原油期货周三收高。1月份西德克萨斯中质原油期货收盘上涨0.14美元,或0.2%,至每桶70.87美元。</blockquote></p><p></p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rebound Anticipated For Singapore Stock Market<blockquote>新加坡股市有望反弹</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRebound Anticipated For Singapore Stock Market<blockquote>新加坡股市有望反弹</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">RTTNews</strong><span class=\"h-time small\">2021-12-16 08:03</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Singapore stock market headed south again on Wednesday, one session after ending the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just beneath the 3,115-point plateau although it figures to bounce higher again on Thursday.</p><p><blockquote>新加坡股市周三再次走低,此前一个交易日结束了连续两天下跌超过20点或0.7%的下跌。海峡时报指数目前略低于 3,115 点的平台位,但预计周四将再次反弹。</blockquote></p><p> The global forecast for the Asian markets is upbeat following results of the FOMC's monetary policy meeting. The European and U.S. markets were solidly higher and the Asian bourses figure to open in similar fashion.</p><p><blockquote>FOMC货币政策会议结果公布后,亚洲市场的全球前景乐观。欧洲和美国市场稳步走高,亚洲股市也将以类似的方式开盘。</blockquote></p><p> The STI finished modestly lower on Wednesday following losses from the properties and industrials, while the financials were mixed.</p><p><blockquote>由于房地产和工业股下跌,STI 周三小幅收低,而金融股涨跌互现。</blockquote></p><p> For the day, the index slid 6.21 points or 0.20 percent to finish at 3,114.88 after trading between 3,106.63 and 3,120.55. Volume was 883.4 million shares worth 761.8 million Singapore dollars. There were 264 decliners and 180 gainers.</p><p><blockquote>当天,该指数在3,106.63至3,120.55之间交易后,下跌6.21点或0.20%,收于3,114.88点。成交量为8.834亿股,价值7.618亿新加坡元。下跌的有264家,上涨的有180家。</blockquote></p><p> Among the actives, Ascendas REIT lost 0.34 percent, while CapitaLand Integrated Commercial Trust retreated 0.50 percent, City Developments sank 0.42 percent, Comfort DelGro jumped 1.45 percent, Dairy Farm International plummeted 2.42 percent, DBS Group rose 0.19 percent, Genting Singapore surrendered 0.64 percent, Keppel Corp shed 0.39 percent, Mapletree Commercial Trust plunged 0.98 percent, Mapletree Logistics Trust declined 0.53 percent, Oversea-Chinese Banking Corporation fell 0.27 percent, SembCorp Industries skidded 0.51 percent, Singapore Airlines dipped 0.20 percent, Singapore Exchange slid 0.21 percent, SingTel dropped 0.41 percent, Thai Beverage tumbled 0.75 percent, United Overseas Bank collected 0.15 percent, Wilmar International tanked 0.96 percent and Yangzijiang Shipbuilding, Singapore Press Holdings, Singapore Technologies Engineering and SATS were unchanged.</p><p><blockquote>资产中,Ascendas REIT下跌0.34%,凯德综合商业信托下跌0.50%,City Developments下跌0.42%,Comfort DelGro上涨1.45%,Dairy Farm International暴跌2.42%,星展集团上涨0.19%,云顶新加坡投降0.64%,吉宝集团下跌0.39%,丰树商业信托暴跌0.98%,丰树物流信托下跌0.53%,华侨银行下跌0.27%,胜科实业下跌0.51%,新加坡航空下跌0.20%,新加坡交易所下跌0.21%,新加坡电信下跌0.41%,泰国饮料下跌0.75%,大华银行上涨0.15%,丰益国际下跌0.96%,扬子江造船、新加坡报业控股、新加坡</blockquote></p><p> The lead from Wall Street is broadly positive as the major averages opened slightly lower on Wednesday but then surged in the afternoon to finish sharply higher.</p><p><blockquote>华尔街的领先优势总体上是积极的,因为主要股指周三开盘小幅走低,但随后在下午飙升,收盘大幅走高。</blockquote></p><p> The Dow soared 383.25 points or 1.08 percent to finish at 35,927.43, while the NASDAQ spiked 327.94 points or 2.15 percent to end at 15,565.58 and the S&P 500 jumped 75.76 points or 1.63 percent to close at 4,709.85.</p><p><blockquote>道琼斯指数飙升383.25点或1.08%,收于35927.43点,而纳斯达克指数飙升327.94点或2.15%,收于15565.58点,标普500指数上涨75.76点或1.63%,收于4709.85点。</blockquote></p><p> The late-day rally on Wall Street came after the Fed announced its widely expected decision to accelerate the pace of reductions to its asset purchases program. Citing inflation developments and further improvement in the labor market, the Fed said it has decided to reduce the monthly pace of its net asset purchases by $30 billion per month, double the previously announced $15 billion per month.</p><p><blockquote>华尔街尾盘上涨之前,美联储宣布了人们普遍预期的加快资产购买计划削减步伐的决定。美联储以通胀发展和劳动力市场进一步改善为由表示,已决定将每月净资产购买速度降低 300 亿美元,是此前宣布的每月 150 亿美元的两倍。</blockquote></p><p> The Fed said it expects similar reductions in the pace of net asset purchases will likely be appropriate each month, pointing to an end to the program next March. Analysts partly attributed the subsequent rally to relief that the Fed was not more aggressive in accelerating the timetable for halting its asset purchases.</p><p><blockquote>美联储表示,预计每月净资产购买步伐的类似降低可能是合适的,这表明该计划将于明年 3 月结束。分析师将随后的反弹部分归因于美联储没有更积极地加快停止资产购买的时间表,这让人松了一口气。</blockquote></p><p> Meanwhile, the Fed also announced its widely expected decision to keep the target range for the federal funds rate at zero to 0.25 percent. The central bank's latest projections forecast as many three rate hikes in 2022 compared to the lone rate hike forecast in September.</p><p><blockquote>与此同时,美联储还宣布了广泛预期的决定,将联邦基金利率目标区间维持在零至0.25%。与 9 月份的唯一一次加息预测相比,央行最新预测 2022 年将加息三次。</blockquote></p><p> Despite the prospect of sooner than expected rate hikes, analysts suggested traders were pleased with the increased level of certainty provided by the Fed's latest projections.</p><p><blockquote>尽管加息前景早于预期,但分析师表示,交易员对美联储最新预测提供的确定性水平的提高感到满意。</blockquote></p><p> Crude oil futures settled higher on Wednesday after the Energy Information Administration (EIA) said crude inventories in the U.S. dropped by 4.6 million barrels last week. West Texas Intermediate crude oil futures for January ended up by $0.14 or 0.2 percent at $70.87 a barrel.</p><p><blockquote>美国能源信息署 (EIA) 表示上周美国原油库存下降 460 万桶后,原油期货周三收高。1月份西德克萨斯中质原油期货收盘上涨0.14美元,或0.2%,至每桶70.87美元。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.rttnews.com/3249611/rebound-anticipated-for-singapore-stock-market.aspx\">RTTNews</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3249611/rebound-anticipated-for-singapore-stock-market.aspx","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194155872","content_text":"The Singapore stock market headed south again on Wednesday, one session after ending the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just beneath the 3,115-point plateau although it figures to bounce higher again on Thursday.\nThe global forecast for the Asian markets is upbeat following results of the FOMC's monetary policy meeting. The European and U.S. markets were solidly higher and the Asian bourses figure to open in similar fashion.\nThe STI finished modestly lower on Wednesday following losses from the properties and industrials, while the financials were mixed.\nFor the day, the index slid 6.21 points or 0.20 percent to finish at 3,114.88 after trading between 3,106.63 and 3,120.55. Volume was 883.4 million shares worth 761.8 million Singapore dollars. There were 264 decliners and 180 gainers.\nAmong the actives, Ascendas REIT lost 0.34 percent, while CapitaLand Integrated Commercial Trust retreated 0.50 percent, City Developments sank 0.42 percent, Comfort DelGro jumped 1.45 percent, Dairy Farm International plummeted 2.42 percent, DBS Group rose 0.19 percent, Genting Singapore surrendered 0.64 percent, Keppel Corp shed 0.39 percent, Mapletree Commercial Trust plunged 0.98 percent, Mapletree Logistics Trust declined 0.53 percent, Oversea-Chinese Banking Corporation fell 0.27 percent, SembCorp Industries skidded 0.51 percent, Singapore Airlines dipped 0.20 percent, Singapore Exchange slid 0.21 percent, SingTel dropped 0.41 percent, Thai Beverage tumbled 0.75 percent, United Overseas Bank collected 0.15 percent, Wilmar International tanked 0.96 percent and Yangzijiang Shipbuilding, Singapore Press Holdings, Singapore Technologies Engineering and SATS were unchanged.\nThe lead from Wall Street is broadly positive as the major averages opened slightly lower on Wednesday but then surged in the afternoon to finish sharply higher.\nThe Dow soared 383.25 points or 1.08 percent to finish at 35,927.43, while the NASDAQ spiked 327.94 points or 2.15 percent to end at 15,565.58 and the S&P 500 jumped 75.76 points or 1.63 percent to close at 4,709.85.\nThe late-day rally on Wall Street came after the Fed announced its widely expected decision to accelerate the pace of reductions to its asset purchases program. Citing inflation developments and further improvement in the labor market, the Fed said it has decided to reduce the monthly pace of its net asset purchases by $30 billion per month, double the previously announced $15 billion per month.\nThe Fed said it expects similar reductions in the pace of net asset purchases will likely be appropriate each month, pointing to an end to the program next March. Analysts partly attributed the subsequent rally to relief that the Fed was not more aggressive in accelerating the timetable for halting its asset purchases.\nMeanwhile, the Fed also announced its widely expected decision to keep the target range for the federal funds rate at zero to 0.25 percent. The central bank's latest projections forecast as many three rate hikes in 2022 compared to the lone rate hike forecast in September.\nDespite the prospect of sooner than expected rate hikes, analysts suggested traders were pleased with the increased level of certainty provided by the Fed's latest projections.\nCrude oil futures settled higher on Wednesday after the Energy Information Administration (EIA) said crude inventories in the U.S. dropped by 4.6 million barrels last week. West Texas Intermediate crude oil futures for January ended up by $0.14 or 0.2 percent at $70.87 a barrel.","news_type":1,"symbols_score_info":{"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":5184,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605267036,"gmtCreate":1639182635685,"gmtModify":1639182635685,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"[What] ","listText":"[What] ","text":"[What]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605267036","repostId":"1148141788","repostType":4,"repost":{"id":"1148141788","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639147224,"share":"https://www.laohunote.com/m/news/1148141788?lang=zh_CN&edition=full","pubTime":"2021-12-10 22:40","market":"us","language":"en","title":"Vaccine stocks dropped in morning trading<blockquote>疫苗股早盘交易中下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1148141788","media":"Tiger Newspress","summary":"Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.","content":"<p>Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.</p><p><blockquote>疫苗股在早盘交易中下跌。Moderna、BioNTech 和 Novavax 下跌 2% 至 11%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d3f84cfc9f83b59cf14210d41d97111a\" tg-width=\"415\" tg-height=\"302\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks dropped in morning trading<blockquote>疫苗股早盘交易中下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks dropped in morning trading<blockquote>疫苗股早盘交易中下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-10 22:40</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.</p><p><blockquote>疫苗股在早盘交易中下跌。Moderna、BioNTech 和 Novavax 下跌 2% 至 11%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d3f84cfc9f83b59cf14210d41d97111a\" tg-width=\"415\" tg-height=\"302\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148141788","content_text":"Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.","news_type":1,"symbols_score_info":{"MRNA":0.9,"BNTX":0.9,"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":4179,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606427974,"gmtCreate":1638922262420,"gmtModify":1638922262420,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"[Grin] ","listText":"[Grin] ","text":"[Grin]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/606427974","repostId":"1159685639","repostType":4,"repost":{"id":"1159685639","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638888367,"share":"https://www.laohunote.com/m/news/1159685639?lang=zh_CN&edition=full","pubTime":"2021-12-07 22:46","market":"us","language":"en","title":"Apple shares rose more than 3% to a new high<blockquote>苹果股价上涨逾3%创新高</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1159685639","media":"Tiger Newspress","summary":"Apple shares rose more than 3% to a new high after the company got another street-high target on vir","content":"<p>Apple shares rose more than 3% to a new high after the company got another street-high target on virtual reality boost.</p><p><blockquote>苹果股价上涨超过 3%,创下新高,此前该公司在虚拟现实提升方面获得了另一个高价目标。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/eb9792aa89d24847aee38f67d56067eb\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Apple Inc. got its second Street-high price target as Morgan Stanley sees it benefiting from new product categories in virtual reality and autonomous vehicles.</p><p><blockquote>摩根士丹利认为苹果公司受益于虚拟现实和自动驾驶汽车的新产品类别,因此获得了第二高的目标价。</blockquote></p><p> Analyst Katy Huberty, who rates Apple overweight, raised her price target to $200 from $164, matching Wedbush as the highest among targets tracked by Bloomberg. </p><p><blockquote>对苹果·跑赢大盘进行评级的分析师凯蒂·休伯蒂 (Katy Huberty) 将目标价从 164 美元上调至 200 美元,与韦德布什持平,成为彭博社追踪的目标中最高的。</blockquote></p><p> While investors have struggled to value the iPhone maker’s new products given the company’s secrecy, Huberty expects augmented and virtual reality, as well as autonomous vehicles, to eventually be priced in, and says Apple should also benefit from a “flight to quality” in technology stocks.</p><p><blockquote>虽然鉴于这家 iPhone 制造商的保密性,投资者一直难以对其新产品进行估值,但休伯蒂预计增强现实和虚拟现实以及自动驾驶汽车最终将被纳入定价,并表示苹果也应该从科技股的 “向质量的转变 ”中受益。</blockquote></p><p> “Despite a consistent and material revenue contribution from new products and services over time, Apple shares don’t seem to bake in the impact from upcoming new product launches,” Huberty wrote in a note. “We believe this will change as Apple approaches the launch of an AR/VR product over the next year.”</p><p><blockquote>“休伯蒂在一份报告中写道:”尽管随着时间的推移,新产品和服务对收入的贡献一直很大,但苹果的股价似乎并没有受到即将推出的新产品的影响。“我们相信,随着苹果明年即将推出 AR/VR 产品,这种情况将会改变。”</blockquote></p><p> <img src=\"https://static.tigerbbs.com/7d1d69bd985c3b74963515674f2da918\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Apple’s shares have surged 25% this year and ended Monday’s session at a fresh record. Investors consider the tech giant a safe bet in an increasingly volatile market, as the highest-valued names in the sector get hit by hawkish signals from the Federal Reserve.</p><p><blockquote>苹果的股价今年以来已飙升 25%,周一收盘时创下新纪录。投资者认为,在日益动荡的市场中,这家科技巨头是一个安全的选择,因为该行业估值最高的公司受到美联储鹰派信号的打击。</blockquote></p><p> Huberty also increased her estimates for Apple’s December quarter, citing improving iPhone supply as manufacturing disruptions ease.</p><p><blockquote>休伯蒂还上调了对苹果 12 月份季度的预期,理由是随着生产中断的缓解,iPhone 供应有所改善。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple shares rose more than 3% to a new high<blockquote>苹果股价上涨逾3%创新高</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple shares rose more than 3% to a new high<blockquote>苹果股价上涨逾3%创新高</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-07 22:46</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Apple shares rose more than 3% to a new high after the company got another street-high target on virtual reality boost.</p><p><blockquote>苹果股价上涨超过 3%,创下新高,此前该公司在虚拟现实提升方面获得了另一个高价目标。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/eb9792aa89d24847aee38f67d56067eb\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Apple Inc. got its second Street-high price target as Morgan Stanley sees it benefiting from new product categories in virtual reality and autonomous vehicles.</p><p><blockquote>摩根士丹利认为苹果公司受益于虚拟现实和自动驾驶汽车的新产品类别,因此获得了第二高的目标价。</blockquote></p><p> Analyst Katy Huberty, who rates Apple overweight, raised her price target to $200 from $164, matching Wedbush as the highest among targets tracked by Bloomberg. </p><p><blockquote>对苹果·跑赢大盘进行评级的分析师凯蒂·休伯蒂 (Katy Huberty) 将目标价从 164 美元上调至 200 美元,与韦德布什持平,成为彭博社追踪的目标中最高的。</blockquote></p><p> While investors have struggled to value the iPhone maker’s new products given the company’s secrecy, Huberty expects augmented and virtual reality, as well as autonomous vehicles, to eventually be priced in, and says Apple should also benefit from a “flight to quality” in technology stocks.</p><p><blockquote>虽然鉴于这家 iPhone 制造商的保密性,投资者一直难以对其新产品进行估值,但休伯蒂预计增强现实和虚拟现实以及自动驾驶汽车最终将被纳入定价,并表示苹果也应该从科技股的 “向质量的转变 ”中受益。</blockquote></p><p> “Despite a consistent and material revenue contribution from new products and services over time, Apple shares don’t seem to bake in the impact from upcoming new product launches,” Huberty wrote in a note. “We believe this will change as Apple approaches the launch of an AR/VR product over the next year.”</p><p><blockquote>“休伯蒂在一份报告中写道:”尽管随着时间的推移,新产品和服务对收入的贡献一直很大,但苹果的股价似乎并没有受到即将推出的新产品的影响。“我们相信,随着苹果明年即将推出 AR/VR 产品,这种情况将会改变。”</blockquote></p><p> <img src=\"https://static.tigerbbs.com/7d1d69bd985c3b74963515674f2da918\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Apple’s shares have surged 25% this year and ended Monday’s session at a fresh record. Investors consider the tech giant a safe bet in an increasingly volatile market, as the highest-valued names in the sector get hit by hawkish signals from the Federal Reserve.</p><p><blockquote>苹果的股价今年以来已飙升 25%,周一收盘时创下新纪录。投资者认为,在日益动荡的市场中,这家科技巨头是一个安全的选择,因为该行业估值最高的公司受到美联储鹰派信号的打击。</blockquote></p><p> Huberty also increased her estimates for Apple’s December quarter, citing improving iPhone supply as manufacturing disruptions ease.</p><p><blockquote>休伯蒂还上调了对苹果 12 月份季度的预期,理由是随着生产中断的缓解,iPhone 供应有所改善。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159685639","content_text":"Apple shares rose more than 3% to a new high after the company got another street-high target on virtual reality boost.\n\nApple Inc. got its second Street-high price target as Morgan Stanley sees it benefiting from new product categories in virtual reality and autonomous vehicles.\nAnalyst Katy Huberty, who rates Apple overweight, raised her price target to $200 from $164, matching Wedbush as the highest among targets tracked by Bloomberg. \nWhile investors have struggled to value the iPhone maker’s new products given the company’s secrecy, Huberty expects augmented and virtual reality, as well as autonomous vehicles, to eventually be priced in, and says Apple should also benefit from a “flight to quality” in technology stocks.\n“Despite a consistent and material revenue contribution from new products and services over time, Apple shares don’t seem to bake in the impact from upcoming new product launches,” Huberty wrote in a note. “We believe this will change as Apple approaches the launch of an AR/VR product over the next year.”\n\nApple’s shares have surged 25% this year and ended Monday’s session at a fresh record. Investors consider the tech giant a safe bet in an increasingly volatile market, as the highest-valued names in the sector get hit by hawkish signals from the Federal Reserve.\nHuberty also increased her estimates for Apple’s December quarter, citing improving iPhone supply as manufacturing disruptions ease.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":4556,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606310868,"gmtCreate":1638833792463,"gmtModify":1638833792463,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606310868","repostId":"1191828969","repostType":2,"repost":{"id":"1191828969","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638792831,"share":"https://www.laohunote.com/m/news/1191828969?lang=zh_CN&edition=full","pubTime":"2021-12-06 20:13","market":"us","language":"en","title":"Grab shares slid more than 4% in premarket trading<blockquote>Grab 股价在盘前交易中下跌超过 4%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1191828969","media":"Tiger Newspress","summary":"Grab shares slid more than 4% in premarket trading.The Singapore ride-hailing firm went on sale last week.","content":"<p>Grab shares slid more than 4% in premarket trading.The Singapore ride-hailing firm went on sale last week.</p><p><blockquote>Grab 股价在盘前交易中下跌超过 4%。这家新加坡叫车公司上周开始出售。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8de30b544b65a645e7a91a37bfb8d8f8\" tg-width=\"851\" tg-height=\"618\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab shares slid more than 4% in premarket trading<blockquote>Grab 股价在盘前交易中下跌超过 4%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab shares slid more than 4% in premarket trading<blockquote>Grab 股价在盘前交易中下跌超过 4%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-06 20:13</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Grab shares slid more than 4% in premarket trading.The Singapore ride-hailing firm went on sale last week.</p><p><blockquote>Grab 股价在盘前交易中下跌超过 4%。这家新加坡叫车公司上周开始出售。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8de30b544b65a645e7a91a37bfb8d8f8\" tg-width=\"851\" tg-height=\"618\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191828969","content_text":"Grab shares slid more than 4% in premarket trading.The Singapore ride-hailing firm went on sale last week.","news_type":1,"symbols_score_info":{"GRAB":0.9}},"isVote":1,"tweetType":1,"viewCount":4252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608147410,"gmtCreate":1638672022759,"gmtModify":1638672022759,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"[Sad] ","listText":"[Sad] ","text":"[Sad]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608147410","repostId":"1115309845","repostType":4,"repost":{"id":"1115309845","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638541913,"share":"https://www.laohunote.com/m/news/1115309845?lang=zh_CN&edition=full","pubTime":"2021-12-03 22:31","market":"us","language":"en","title":"Stocks gain on Friday to close out volatile week triggered by omicron fears<blockquote>周五股市上涨,结束了因奥密克戎担忧引发的动荡一周</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1115309845","media":"Tiger Newspress","summary":"Stocks rose in early trading Friday, looking past a disappointing November jobs report, as the marke","content":"<p>Stocks rose in early trading Friday, looking past a disappointing November jobs report, as the market nears the end of a roller-coaster week driven by Covid omicron variant developments.</p><p><blockquote>周五早盘交易中,股市上涨,回顾了令人失望的 11 月就业报告,因为市场接近由新冠病毒奥密克戎变体发展推动的过山车周的尾声。</blockquote></p><p> The Dow Jones Industrial Average rose about 100 points. The S&P 500 rose 0.43% and the technology-focused Nasdaq Composite rose 0.3%.</p><p><blockquote>道琼斯工业平均指数上涨约100点。标普500上涨0.43%,以科技为主的纳斯达克综合指数上涨0.3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f06b0aca63dcdc023083815943f6832a\" tg-width=\"1057\" tg-height=\"455\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> RLX Technology stock tumbled 6% as its Q3 <b>Net revenues</b> decreased by 34%.</p><p><blockquote>RLX科技第三季度股价下跌 6%<b>净收入</b>下降了34%。</blockquote></p><p> Marvell Technology shares soared 20% after delivering a better-than-expected earnings report and outlook.</p><p><blockquote>Marvell Technology 发布好于预期的收益报告和展望后,股价飙升 20%。</blockquote></p><p> DocuSign shares tumbled 35% on Weak Sales Forecast.</p><p><blockquote>由于销售预测疲软,DocuSign 股价暴跌 35%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks gain on Friday to close out volatile week triggered by omicron fears<blockquote>周五股市上涨,结束了因奥密克戎担忧引发的动荡一周</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks gain on Friday to close out volatile week triggered by omicron fears<blockquote>周五股市上涨,结束了因奥密克戎担忧引发的动荡一周</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-03 22:31</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Stocks rose in early trading Friday, looking past a disappointing November jobs report, as the market nears the end of a roller-coaster week driven by Covid omicron variant developments.</p><p><blockquote>周五早盘交易中,股市上涨,回顾了令人失望的 11 月就业报告,因为市场接近由新冠病毒奥密克戎变体发展推动的过山车周的尾声。</blockquote></p><p> The Dow Jones Industrial Average rose about 100 points. The S&P 500 rose 0.43% and the technology-focused Nasdaq Composite rose 0.3%.</p><p><blockquote>道琼斯工业平均指数上涨约100点。标普500上涨0.43%,以科技为主的纳斯达克综合指数上涨0.3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f06b0aca63dcdc023083815943f6832a\" tg-width=\"1057\" tg-height=\"455\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> RLX Technology stock tumbled 6% as its Q3 <b>Net revenues</b> decreased by 34%.</p><p><blockquote>RLX科技第三季度股价下跌 6%<b>净收入</b>下降了34%。</blockquote></p><p> Marvell Technology shares soared 20% after delivering a better-than-expected earnings report and outlook.</p><p><blockquote>Marvell Technology 发布好于预期的收益报告和展望后,股价飙升 20%。</blockquote></p><p> DocuSign shares tumbled 35% on Weak Sales Forecast.</p><p><blockquote>由于销售预测疲软,DocuSign 股价暴跌 35%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115309845","content_text":"Stocks rose in early trading Friday, looking past a disappointing November jobs report, as the market nears the end of a roller-coaster week driven by Covid omicron variant developments.\nThe Dow Jones Industrial Average rose about 100 points. The S&P 500 rose 0.43% and the technology-focused Nasdaq Composite rose 0.3%.\n\nRLX Technology stock tumbled 6% as its Q3 Net revenues decreased by 34%.\nMarvell Technology shares soared 20% after delivering a better-than-expected earnings report and outlook.\nDocuSign shares tumbled 35% on Weak Sales Forecast.","news_type":1,"symbols_score_info":{".IXIC":0.9,".DJI":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":4086,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603593459,"gmtCreate":1638422373223,"gmtModify":1638422373401,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/603593459","repostId":"1143092770","repostType":4,"repost":{"id":"1143092770","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638370804,"share":"https://www.laohunote.com/m/news/1143092770?lang=zh_CN&edition=full","pubTime":"2021-12-01 23:00","market":"us","language":"en","title":"Apple shares rose nearly 2% to a new high<blockquote>苹果股价上涨近2%创新高</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1143092770","media":"Tiger Newspress","summary":"Apple shares rose nearly 2% to a new high in morning trading.\nNeedham analyst Laura Martin said inve","content":"<p>Apple shares rose nearly 2% to a new high in morning trading.</p><p><blockquote>苹果股价在早盘交易中上涨近2%,创下新高。</blockquote></p><p> <b>Needham</b> analyst Laura Martin said investors turned to Apple due to its prodigious cash flow capable of weathering the storm, not going bankrupt, not having financial distress.</p><p><blockquote><b>李约瑟</b>分析师 Laura Martin 表示,投资者转向苹果是因为其惊人的现金流能够经受住风暴,不会破产,也不会陷入财务困境。</blockquote></p><p> Martin said there are indications that Apple’s current products, especially its iPhone Pro models, are selling well, potentially leading to a big December quarter for the company.</p><p><blockquote>Martin 说,有迹象表明,苹果目前的产品,尤其是 iPhone Pro 机型,销量很好,这可能会给该公司带来一个大的 12 月份季度。</blockquote></p><p> Tablets, especially the high-end iPhones, all of which say they’re going to have high margins and high revenue for the fourth quarter of this year, Martin added.</p><p><blockquote>马丁补充说,平板电脑,尤其是高端 iPhone,都表示今年第四季度将实现高利润率和高收入。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/edc1b3fcbf75cefc8acb5fa15512530b\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple shares rose nearly 2% to a new high<blockquote>苹果股价上涨近2%创新高</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple shares rose nearly 2% to a new high<blockquote>苹果股价上涨近2%创新高</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-01 23:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Apple shares rose nearly 2% to a new high in morning trading.</p><p><blockquote>苹果股价在早盘交易中上涨近2%,创下新高。</blockquote></p><p> <b>Needham</b> analyst Laura Martin said investors turned to Apple due to its prodigious cash flow capable of weathering the storm, not going bankrupt, not having financial distress.</p><p><blockquote><b>李约瑟</b>分析师 Laura Martin 表示,投资者转向苹果是因为其惊人的现金流能够经受住风暴,不会破产,也不会陷入财务困境。</blockquote></p><p> Martin said there are indications that Apple’s current products, especially its iPhone Pro models, are selling well, potentially leading to a big December quarter for the company.</p><p><blockquote>Martin 说,有迹象表明,苹果目前的产品,尤其是 iPhone Pro 机型,销量很好,这可能会给该公司带来一个大的 12 月份季度。</blockquote></p><p> Tablets, especially the high-end iPhones, all of which say they’re going to have high margins and high revenue for the fourth quarter of this year, Martin added.</p><p><blockquote>马丁补充说,平板电脑,尤其是高端 iPhone,都表示今年第四季度将实现高利润率和高收入。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/edc1b3fcbf75cefc8acb5fa15512530b\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143092770","content_text":"Apple shares rose nearly 2% to a new high in morning trading.\nNeedham analyst Laura Martin said investors turned to Apple due to its prodigious cash flow capable of weathering the storm, not going bankrupt, not having financial distress.\nMartin said there are indications that Apple’s current products, especially its iPhone Pro models, are selling well, potentially leading to a big December quarter for the company.\nTablets, especially the high-end iPhones, all of which say they’re going to have high margins and high revenue for the fourth quarter of this year, Martin added.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":3138,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609716514,"gmtCreate":1638325513244,"gmtModify":1638325513244,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609716514","repostId":"1129769141","repostType":4,"repost":{"id":"1129769141","kind":"news","pubTimestamp":1638317199,"share":"https://www.laohunote.com/m/news/1129769141?lang=zh_CN&edition=full","pubTime":"2021-12-01 08:06","market":"us","language":"en","title":"Oversold Singapore Bourse Called Lower Again<blockquote>超卖新加坡证券交易所再次走低</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1129769141","media":"RTTNews","summary":"The Singapore stock market has finished lower in six straight trading days, sinking almost 200 point","content":"<p>The Singapore stock market has finished lower in six straight trading days, sinking almost 200 points or 6.4 percent along the way. The Straits Times Index now sits just above the 3,040-point plateau and it's got another weak lead for Wednesday's trade.</p><p><blockquote>新加坡股市连续六个交易日收低,一路下跌近200点或6.4%。海峡时报指数目前位于 3,040 点平台上方,周三交易中再次出现弱势领先优势。</blockquote></p><p> The global forecast for the Asian markets suggests consolidation on continued COVID-19 worries and concerns over the outlook for interest rates. The European and U.S. markets were down and the Asian markets figure to open in similar fashion.</p><p><blockquote>亚洲市场的全球预测表明,由于持续的新冠肺炎担忧和对利率前景的担忧,亚洲市场将出现盘整。欧洲和美国市场下跌,亚洲市场预计也将以类似的方式开盘。</blockquote></p><p> The STI finished sharply lower on Tuesday with damage across the board, especially from the financials and industrials.</p><p><blockquote>STI 周二大幅收低,全线受损,尤其是金融和工业股。</blockquote></p><p> For the day, the index plunged 79.29 points or 2.54 percent to finish at the daily low of 3,041.29 after peaking at 3,129.54. Volume was 3.22 billion shares worth 3.89 billion Singapore dollars. There were 338 decliners and 172 gainers.</p><p><blockquote>当天,该指数暴跌 79.29 点或 2.54%,在触及 3,129.54 点的峰值后,收于 3,041.29 点的日低点。成交量为32.2亿股,价值38.9亿新加坡元。下跌者338人,上涨者172人。</blockquote></p><p> Among the actives, Ascendas REIT slumped 2.34 percent, while CapitaLand Integrated Commercial Trust and Jardine Cycle both fell 1.40 percent, City Developments added 0.29 percent, Comfort DelGro plummeted 4.20 percent, Dairy Farm International and Thai Beverage both weakened 2.19 percent, DBS Group declined 2.99 percent, Genting Singapore skidded 2.53 percent, Keppel Corp sank 2.11 percent, Mapletree Commercial Trust stumbled 2.39 percent, Mapletree Logistics Trust lost 1.87 percent, Oversea-Chinese Banking Corporation surrendered 3.17 percent, SATS retreated 2.56 percent, SembCorp Industries plunged 4.08 percent, Singapore Airlines slid 0.81 percent, Singapore Exchange tumbled 3.25 percent, Singapore Press Holdings eased 0.43 percent, Singapore Technologies Engineering was down 0.78 percent, SingTel dropped 2.07 percent, United Overseas Bank tanked 4.00 percent, Wilmar International shed 1.91 percent and Yangzijiang Shipbuilding was unchanged.</p><p><blockquote>资产中,Ascendas REIT 下跌 2.34%,凯德综合商业信托和怡和自行车均下跌 1.40%,City Developments 上涨 0.29%,Comfort DelGro 下跌 4.20%,Dairy Farm International 和 Thai Beverage 均下跌 2.19%,星展集团下跌 2.99%,云顶新加坡下跌 2.53%,吉宝集团下跌 2.11%,丰树商业信托下跌 2.39%,丰树物流信托下跌 1.87%,华侨银行股份有限公司投降 3.17%,SATS 下跌 2.56%,胜科工业股份有限公司暴跌 4.08%,新加坡航空公司下跌 0.81%,新加坡交易所下跌 3.25%,新加坡报业控股公司下跌 0.43%,新加坡科技工程下跌 0.78%,新加坡电信下跌 2.2%</blockquote></p><p> The lead from Wall Street is broadly negative as the major averages opened lower on Tuesday and remained largely under water throughout the trading day.</p><p><blockquote>华尔街的领先优势普遍为负面,因为主要股指周二开盘走低,并且整个交易日基本处于水下。</blockquote></p><p></p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oversold Singapore Bourse Called Lower Again<blockquote>超卖新加坡证券交易所再次走低</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOversold Singapore Bourse Called Lower Again<blockquote>超卖新加坡证券交易所再次走低</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">RTTNews</strong><span class=\"h-time small\">2021-12-01 08:06</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Singapore stock market has finished lower in six straight trading days, sinking almost 200 points or 6.4 percent along the way. The Straits Times Index now sits just above the 3,040-point plateau and it's got another weak lead for Wednesday's trade.</p><p><blockquote>新加坡股市连续六个交易日收低,一路下跌近200点或6.4%。海峡时报指数目前位于 3,040 点平台上方,周三交易中再次出现弱势领先优势。</blockquote></p><p> The global forecast for the Asian markets suggests consolidation on continued COVID-19 worries and concerns over the outlook for interest rates. The European and U.S. markets were down and the Asian markets figure to open in similar fashion.</p><p><blockquote>亚洲市场的全球预测表明,由于持续的新冠肺炎担忧和对利率前景的担忧,亚洲市场将出现盘整。欧洲和美国市场下跌,亚洲市场预计也将以类似的方式开盘。</blockquote></p><p> The STI finished sharply lower on Tuesday with damage across the board, especially from the financials and industrials.</p><p><blockquote>STI 周二大幅收低,全线受损,尤其是金融和工业股。</blockquote></p><p> For the day, the index plunged 79.29 points or 2.54 percent to finish at the daily low of 3,041.29 after peaking at 3,129.54. Volume was 3.22 billion shares worth 3.89 billion Singapore dollars. There were 338 decliners and 172 gainers.</p><p><blockquote>当天,该指数暴跌 79.29 点或 2.54%,在触及 3,129.54 点的峰值后,收于 3,041.29 点的日低点。成交量为32.2亿股,价值38.9亿新加坡元。下跌者338人,上涨者172人。</blockquote></p><p> Among the actives, Ascendas REIT slumped 2.34 percent, while CapitaLand Integrated Commercial Trust and Jardine Cycle both fell 1.40 percent, City Developments added 0.29 percent, Comfort DelGro plummeted 4.20 percent, Dairy Farm International and Thai Beverage both weakened 2.19 percent, DBS Group declined 2.99 percent, Genting Singapore skidded 2.53 percent, Keppel Corp sank 2.11 percent, Mapletree Commercial Trust stumbled 2.39 percent, Mapletree Logistics Trust lost 1.87 percent, Oversea-Chinese Banking Corporation surrendered 3.17 percent, SATS retreated 2.56 percent, SembCorp Industries plunged 4.08 percent, Singapore Airlines slid 0.81 percent, Singapore Exchange tumbled 3.25 percent, Singapore Press Holdings eased 0.43 percent, Singapore Technologies Engineering was down 0.78 percent, SingTel dropped 2.07 percent, United Overseas Bank tanked 4.00 percent, Wilmar International shed 1.91 percent and Yangzijiang Shipbuilding was unchanged.</p><p><blockquote>资产中,Ascendas REIT 下跌 2.34%,凯德综合商业信托和怡和自行车均下跌 1.40%,City Developments 上涨 0.29%,Comfort DelGro 下跌 4.20%,Dairy Farm International 和 Thai Beverage 均下跌 2.19%,星展集团下跌 2.99%,云顶新加坡下跌 2.53%,吉宝集团下跌 2.11%,丰树商业信托下跌 2.39%,丰树物流信托下跌 1.87%,华侨银行股份有限公司投降 3.17%,SATS 下跌 2.56%,胜科工业股份有限公司暴跌 4.08%,新加坡航空公司下跌 0.81%,新加坡交易所下跌 3.25%,新加坡报业控股公司下跌 0.43%,新加坡科技工程下跌 0.78%,新加坡电信下跌 2.2%</blockquote></p><p> The lead from Wall Street is broadly negative as the major averages opened lower on Tuesday and remained largely under water throughout the trading day.</p><p><blockquote>华尔街的领先优势普遍为负面,因为主要股指周二开盘走低,并且整个交易日基本处于水下。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.rttnews.com/3245823/oversold-singapore-bourse-called-lower-again.aspx?type=acom\">RTTNews</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数","BVA.SI":"顶级手套有限公司","C6L.SI":"新加坡航空公司","D05.SI":"星展集团控股","O39.SI":"华侨银行"},"source_url":"https://www.rttnews.com/3245823/oversold-singapore-bourse-called-lower-again.aspx?type=acom","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129769141","content_text":"The Singapore stock market has finished lower in six straight trading days, sinking almost 200 points or 6.4 percent along the way. The Straits Times Index now sits just above the 3,040-point plateau and it's got another weak lead for Wednesday's trade.\nThe global forecast for the Asian markets suggests consolidation on continued COVID-19 worries and concerns over the outlook for interest rates. The European and U.S. markets were down and the Asian markets figure to open in similar fashion.\nThe STI finished sharply lower on Tuesday with damage across the board, especially from the financials and industrials.\nFor the day, the index plunged 79.29 points or 2.54 percent to finish at the daily low of 3,041.29 after peaking at 3,129.54. Volume was 3.22 billion shares worth 3.89 billion Singapore dollars. There were 338 decliners and 172 gainers.\nAmong the actives, Ascendas REIT slumped 2.34 percent, while CapitaLand Integrated Commercial Trust and Jardine Cycle both fell 1.40 percent, City Developments added 0.29 percent, Comfort DelGro plummeted 4.20 percent, Dairy Farm International and Thai Beverage both weakened 2.19 percent, DBS Group declined 2.99 percent, Genting Singapore skidded 2.53 percent, Keppel Corp sank 2.11 percent, Mapletree Commercial Trust stumbled 2.39 percent, Mapletree Logistics Trust lost 1.87 percent, Oversea-Chinese Banking Corporation surrendered 3.17 percent, SATS retreated 2.56 percent, SembCorp Industries plunged 4.08 percent, Singapore Airlines slid 0.81 percent, Singapore Exchange tumbled 3.25 percent, Singapore Press Holdings eased 0.43 percent, Singapore Technologies Engineering was down 0.78 percent, SingTel dropped 2.07 percent, United Overseas Bank tanked 4.00 percent, Wilmar International shed 1.91 percent and Yangzijiang Shipbuilding was unchanged.\nThe lead from Wall Street is broadly negative as the major averages opened lower on Tuesday and remained largely under water throughout the trading day.","news_type":1,"symbols_score_info":{"D05.SI":0.9,"STI.SI":0.9,"BVA.SI":0.9,"O39.SI":0.9,"C6L.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":4929,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600657865,"gmtCreate":1638150179895,"gmtModify":1638150179895,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/600657865","repostId":"1114522326","repostType":4,"isVote":1,"tweetType":1,"viewCount":3757,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875170549,"gmtCreate":1637628510437,"gmtModify":1637628510437,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"interesting ","listText":"interesting ","text":"interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875170549","repostId":"1144786882","repostType":4,"repost":{"id":"1144786882","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga Earnings","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1637627337,"share":"https://www.laohunote.com/m/news/1144786882?lang=zh_CN&edition=full","pubTime":"2021-11-23 08:28","market":"us","language":"en","title":"Can Apple Close Above The All-Time Highs This Week? Option Analysis<blockquote>苹果本周能否收于历史高点之上?期权分析</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1144786882","media":"Benzinga Earnings","summary":"What Happened:Apple Inc is having a volatile day, initially up over 2.5% but having since lost all o","content":"<p><b>What Happened:Apple Inc</b> is having a volatile day, initially up over 2.5% but having since lost all of those gains over the last two hours of trading.</p><p><blockquote><b>发生了什么:苹果公司</b>今天波动较大,最初上涨超过 2.5%,但在过去两个小时的交易中失去了所有涨幅。</blockquote></p><p> Trading activity has been strong with over 104 million shares on the day versus the 10-day average of 78 million. The recent sell-off late in the session might be due to supply constraints out of Asia for the upcoming holiday shopping season.</p><p><blockquote>交易活动强劲,当天交易量超过 1.04 亿股,而 10 天平均水平为 7800 万股。最近尾盘的抛售可能是由于即将到来的假日购物季亚洲以外的供应紧张。</blockquote></p><p> But what is fascinating is the heavy level of options activity in the stock today with <b>over 2.73 million contracts traded on the day</b> (see below).</p><p><blockquote>但令人着迷的是,今天该股的期权活动水平很高<b>当天交易超过273万份合约</b>(见下文)。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1a3445e396564690250472543787b2dd\" tg-width=\"1002\" tg-height=\"277\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> <b>Why It Matters:</b>Prior to Monday, Apple had approximately 4.1 million calls and 3.3 million puts for a total of 7.4 million options. Thus, today's 2.7+ million options represent <b>a massive 36% increase in options in one day.</b></p><p><blockquote><b>为什么重要:</b>周一之前,苹果拥有约 410 万份评级和 330 万份看跌期权,总计 740 万份期权。因此,今天的 270 多万份期权代表<b>期权在一天内大幅增加了36%。</b></blockquote></p><p> Any time a stock trades 36% of the total options in one day, it suggests option traders are highly active in the stock. And considering 73% of the options traded were calls, it suggests option traders have a strong bullish bias.</p><p><blockquote>任何时候一只股票在一天内交易了总期权的 36%,都表明期权交易者在该股票中非常活跃。考虑到交易的期权中有 73% 是评级,这表明期权交易者有强烈的看涨偏见。</blockquote></p><p> <b>What's Next:</b> About half of the option flows today were short-dated (expiring Friday) with the largest concentration of strikes between $160 and $170 (image below).</p><p><blockquote><b>下一步:</b>今天大约一半的期权流是短期(周五到期),行权最集中在 160 美元至 170 美元之间(下图)。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/fdaae290e3e5538e2f6697fe9cbc40e9\" tg-width=\"1105\" tg-height=\"319\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> The short-dated calls suggest option traders are targeting a range between $160 and $170 for the week. However, with the strong sell-off into the close, the stock could probe below the $160 strike.</p><p><blockquote>短期评级表明,期权交易者本周的目标区间为 160 美元至 170 美元。然而,随着收盘时的强劲抛售,该股可能会跌破 160 美元。</blockquote></p><p> If Apple loses the $160 level, there is solid open interest down to the $155 strike, but falls off materially below that, so any sharp moves below here could represent a bigger selloff in the stock.</p><p><blockquote>如果苹果失去 160 美元的水平,则有坚实的未平仓合约跌至 155 美元的执行价,但大幅跌破该水平,因此任何低于该水平的大幅波动都可能代表该股的更大抛售。</blockquote></p><p> Meanwhile, if the stock can break the all-time highs just above $165, there is potentially room for a move up towards the $175 level.</p><p><blockquote>与此同时,如果该股能够突破略高于 165 美元的历史高点,则有可能上涨至 175 美元的水平。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Apple Close Above The All-Time Highs This Week? Option Analysis<blockquote>苹果本周能否收于历史高点之上?期权分析</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Apple Close Above The All-Time Highs This Week? Option Analysis<blockquote>苹果本周能否收于历史高点之上?期权分析</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time smaller\">2021-11-23 08:28</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><b>What Happened:Apple Inc</b> is having a volatile day, initially up over 2.5% but having since lost all of those gains over the last two hours of trading.</p><p><blockquote><b>发生了什么:苹果公司</b>今天波动较大,最初上涨超过 2.5%,但在过去两个小时的交易中失去了所有涨幅。</blockquote></p><p> Trading activity has been strong with over 104 million shares on the day versus the 10-day average of 78 million. The recent sell-off late in the session might be due to supply constraints out of Asia for the upcoming holiday shopping season.</p><p><blockquote>交易活动强劲,当天交易量超过 1.04 亿股,而 10 天平均水平为 7800 万股。最近尾盘的抛售可能是由于即将到来的假日购物季亚洲以外的供应紧张。</blockquote></p><p> But what is fascinating is the heavy level of options activity in the stock today with <b>over 2.73 million contracts traded on the day</b> (see below).</p><p><blockquote>但令人着迷的是,今天该股的期权活动水平很高<b>当天交易超过273万份合约</b>(见下文)。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1a3445e396564690250472543787b2dd\" tg-width=\"1002\" tg-height=\"277\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> <b>Why It Matters:</b>Prior to Monday, Apple had approximately 4.1 million calls and 3.3 million puts for a total of 7.4 million options. Thus, today's 2.7+ million options represent <b>a massive 36% increase in options in one day.</b></p><p><blockquote><b>为什么重要:</b>周一之前,苹果拥有约 410 万份评级和 330 万份看跌期权,总计 740 万份期权。因此,今天的 270 多万份期权代表<b>期权在一天内大幅增加了36%。</b></blockquote></p><p> Any time a stock trades 36% of the total options in one day, it suggests option traders are highly active in the stock. And considering 73% of the options traded were calls, it suggests option traders have a strong bullish bias.</p><p><blockquote>任何时候一只股票在一天内交易了总期权的 36%,都表明期权交易者在该股票中非常活跃。考虑到交易的期权中有 73% 是评级,这表明期权交易者有强烈的看涨偏见。</blockquote></p><p> <b>What's Next:</b> About half of the option flows today were short-dated (expiring Friday) with the largest concentration of strikes between $160 and $170 (image below).</p><p><blockquote><b>下一步:</b>今天大约一半的期权流是短期(周五到期),行权最集中在 160 美元至 170 美元之间(下图)。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/fdaae290e3e5538e2f6697fe9cbc40e9\" tg-width=\"1105\" tg-height=\"319\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> The short-dated calls suggest option traders are targeting a range between $160 and $170 for the week. However, with the strong sell-off into the close, the stock could probe below the $160 strike.</p><p><blockquote>短期评级表明,期权交易者本周的目标区间为 160 美元至 170 美元。然而,随着收盘时的强劲抛售,该股可能会跌破 160 美元。</blockquote></p><p> If Apple loses the $160 level, there is solid open interest down to the $155 strike, but falls off materially below that, so any sharp moves below here could represent a bigger selloff in the stock.</p><p><blockquote>如果苹果失去 160 美元的水平,则有坚实的未平仓合约跌至 155 美元的执行价,但大幅跌破该水平,因此任何低于该水平的大幅波动都可能代表该股的更大抛售。</blockquote></p><p> Meanwhile, if the stock can break the all-time highs just above $165, there is potentially room for a move up towards the $175 level.</p><p><blockquote>与此同时,如果该股能够突破略高于 165 美元的历史高点,则有可能上涨至 175 美元的水平。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144786882","content_text":"What Happened:Apple Inc is having a volatile day, initially up over 2.5% but having since lost all of those gains over the last two hours of trading.\nTrading activity has been strong with over 104 million shares on the day versus the 10-day average of 78 million. The recent sell-off late in the session might be due to supply constraints out of Asia for the upcoming holiday shopping season.\nBut what is fascinating is the heavy level of options activity in the stock today with over 2.73 million contracts traded on the day (see below).\n\nWhy It Matters:Prior to Monday, Apple had approximately 4.1 million calls and 3.3 million puts for a total of 7.4 million options. Thus, today's 2.7+ million options represent a massive 36% increase in options in one day.\nAny time a stock trades 36% of the total options in one day, it suggests option traders are highly active in the stock. And considering 73% of the options traded were calls, it suggests option traders have a strong bullish bias.\nWhat's Next: About half of the option flows today were short-dated (expiring Friday) with the largest concentration of strikes between $160 and $170 (image below).\n\nThe short-dated calls suggest option traders are targeting a range between $160 and $170 for the week. However, with the strong sell-off into the close, the stock could probe below the $160 strike.\nIf Apple loses the $160 level, there is solid open interest down to the $155 strike, but falls off materially below that, so any sharp moves below here could represent a bigger selloff in the stock.\nMeanwhile, if the stock can break the all-time highs just above $165, there is potentially room for a move up towards the $175 level.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":4834,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875170061,"gmtCreate":1637628442357,"gmtModify":1637628442357,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/875170061","repostId":"1122322848","repostType":4,"isVote":1,"tweetType":1,"viewCount":2011,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872766499,"gmtCreate":1637576322119,"gmtModify":1637576322119,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/872766499","repostId":"2185826772","repostType":4,"isVote":1,"tweetType":1,"viewCount":1318,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876175969,"gmtCreate":1637286640802,"gmtModify":1637286640802,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876175969","repostId":"1168345410","repostType":4,"isVote":1,"tweetType":1,"viewCount":1366,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878226325,"gmtCreate":1637199210060,"gmtModify":1637199210060,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"Okay ","listText":"Okay ","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/878226325","repostId":"1180752156","repostType":4,"isVote":1,"tweetType":1,"viewCount":1149,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871759657,"gmtCreate":1637115093499,"gmtModify":1637115101793,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871759657","repostId":"1185179037","repostType":4,"isVote":1,"tweetType":1,"viewCount":1265,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873664166,"gmtCreate":1636939001730,"gmtModify":1636939001730,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"Okay!","listText":"Okay!","text":"Okay!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873664166","repostId":"1102708415","repostType":4,"isVote":1,"tweetType":1,"viewCount":1368,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879457626,"gmtCreate":1636767229986,"gmtModify":1636767229986,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"interesting ","listText":"interesting ","text":"interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879457626","repostId":"1163118124","repostType":4,"isVote":1,"tweetType":1,"viewCount":1265,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879230715,"gmtCreate":1636727014411,"gmtModify":1636727014411,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"Okay nice","listText":"Okay nice","text":"Okay nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879230715","repostId":"1104158261","repostType":4,"isVote":1,"tweetType":1,"viewCount":1489,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847697615,"gmtCreate":1636511453772,"gmtModify":1636511453902,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"okay ","listText":"okay ","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847697615","repostId":"1179672442","repostType":4,"isVote":1,"tweetType":1,"viewCount":956,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844155652,"gmtCreate":1636413228442,"gmtModify":1636413228916,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844155652","repostId":"1190184675","repostType":4,"repost":{"id":"1190184675","kind":"news","pubTimestamp":1636384600,"share":"https://www.laohunote.com/m/news/1190184675?lang=zh_CN&edition=full","pubTime":"2021-11-08 23:16","market":"us","language":"en","title":"Buffett Signals Caution With Berkshire on Stock-Selling Streak<blockquote>巴菲特对伯克希尔哈撒韦公司连续抛售股票表示谨慎</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1190184675","media":"Bloomberg","summary":"(Bloomberg) -- Warren Buffett is signaling wariness with the soaring stock market as the billionaire","content":"<p><div> (Bloomberg) -- Warren Buffett is signaling wariness with the soaring stock market as the billionaire investor extends a selling streak. Buffett’s Berkshire Hathaway Inc. was a net seller of equities ...</p><p><blockquote><div>(彭博社)——随着这位亿万富翁投资者延续抛售势头,沃伦·巴菲特对股市飙升表示警惕。巴菲特的伯克希尔哈撒韦公司是股票的净卖家……</div></blockquote></p><p> <a href=\"https://finance.yahoo.com/news/buffett-signals-caution-berkshire-stock-140819517.html\">网页链接</a> </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/buffett-signals-caution-berkshire-stock-140819517.html\">网页连接</a></blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett Signals Caution With Berkshire on Stock-Selling Streak<blockquote>巴菲特对伯克希尔哈撒韦公司连续抛售股票表示谨慎</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett Signals Caution With Berkshire on Stock-Selling Streak<blockquote>巴菲特对伯克希尔哈撒韦公司连续抛售股票表示谨慎</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Bloomberg</strong><span class=\"h-time small\">2021-11-08 23:16</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> (Bloomberg) -- Warren Buffett is signaling wariness with the soaring stock market as the billionaire investor extends a selling streak. Buffett’s Berkshire Hathaway Inc. was a net seller of equities ...</p><p><blockquote><div>(彭博社)——随着这位亿万富翁投资者延续抛售势头,沃伦·巴菲特对股市飙升表示警惕。巴菲特的伯克希尔哈撒韦公司是股票的净卖家……</div></blockquote></p><p> <a href=\"https://finance.yahoo.com/news/buffett-signals-caution-berkshire-stock-140819517.html\">网页链接</a> </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/buffett-signals-caution-berkshire-stock-140819517.html\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://finance.yahoo.com/news/buffett-signals-caution-berkshire-stock-140819517.html\">Bloomberg</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.A":"伯克希尔","BRK.B":"伯克希尔B"},"source_url":"https://finance.yahoo.com/news/buffett-signals-caution-berkshire-stock-140819517.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190184675","content_text":"(Bloomberg) -- Warren Buffett is signaling wariness with the soaring stock market as the billionaire investor extends a selling streak.\nBuffett’s Berkshire Hathaway Inc. was a net seller of equities for the fourth straight quarter, a trend not seen in data going back to 2008. The company ended up selling almost $2 billion more in stocks than it purchased during the period, adding to a cash pile that climbed to a record $149.2 billion.\nThe selling streak indicates Buffett has struggled to find bargains with the stock market hitting all-time highs. A big, splashy acquisition also eluded the conglomerate, as the 91-year old and his investing deputies confronted a combination of sky-high price tags and fierce competition from the wave of special purpose acquisition companies.\n“The big issue here is that Berkshire was a net seller of stocks again this quarter,” Jim Shanahan, an analyst with Edward Jones, said in a telephone interview. “That’s the primary culprit” of the cash pile continuing to rise.\nBerkshire’s sales appear to have largely come from cutting holdings in banks, insurance and financial investments, according to its third-quarter regulatory filing released Saturday. Berkshire has been paring certain stocks in recent periods, spending the second quarter trimming its investment in General Motors Co. and pulling back on some of its pharmaceutical bets. The company is set to release its third-quarter stock tweaks later this month.\nWhile Buffett’s been a consistent net seller these past four quarters, those sales have been relatively small compared with the massive size of his stock portfolio. Over the past nine months, he’s sold almost $7 billion more of stocks than he’s bought, roughly 2.2% of the fair value of Berkshire’s stock portfolio at the end of September.\nBuffett warned investors in May that Berkshire might not have much luck striking deals as SPACs gripped the market -- though he also predicted the boom probably wouldn’t last. Compounding the challenge, his most recent big acquisition, the $37 billion deal for Precision Castparts five years ago, resulted in a writedown that Buffett laid squarely at his own door.\nBerkshire isn’t alone in extending a cash pile amid the pandemic. Amazon.com Inc., Google-parent Alphabet Inc. and American Airlines Group Inc. were among companies that amassed significant holdings during the health crisis in a step analysts have said would likely lead to some acquisitions.\nAnd the rising cash pile is better than the alternative in the eyes of investors including Cheviot Value Management’s Darren Pollock. Even though Buffett’s cash pile still increased to a record despite the $7.6 billion of buybacks in the third quarter, Pollock says it’s a good sign about the health of Berkshire.\n“We’re happy with it because the alternative is that cash isn’t growing as much and that means that Berkshire’s operating companies aren’t of as high quality as we thought,” said Pollock, whose Cheviot owns shares in Berkshire. “To see that the cash is rising, to see that he’s deploying so much in one avenue which happens to be buybacks -- it’s not acquisitions -- but it’s being spent in a productive way, it’s so much better than the alternative of seeing that cash stabilize or decline without other large acquisitions.”\nHere are some other key takeaways from Berkshire’s third-quarter earnings on Saturday:\nBerkshire Appetite\nBuffett has increasingly leaned on share buybacks as one way to deploy billions of dollars. He’s spent about $51 billion on stock buybacks since a policy tweak in 2018, outpacing the $31 billion used to purchase shares of Apple Inc., Berkshire’s largest stock bet.\nIn the third quarter, Berkshire bought back $7.6 billion of stock, surpassing the $6 billion of shares repurchased in the previous period.\nBNSF’s Record\nRecord profit at Berkshire’s railroad, BNSF, and strong earnings from its energy businesses helped raise operating profit by 18% at the conglomerate during the third quarter.\nThat also aided in offsetting a painful quarter for Berkshire’s insurers. Those businesses reported an underwriting loss that widened to $784 million amid heightened catastrophe costs and worsening claims trends at auto insurer Geico.","news_type":1,"symbols_score_info":{"BRK.B":0.9,"BRK.A":0.9}},"isVote":1,"tweetType":1,"viewCount":902,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":600657865,"gmtCreate":1638150179895,"gmtModify":1638150179895,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/600657865","repostId":"1114522326","repostType":4,"isVote":1,"tweetType":1,"viewCount":3757,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878226325,"gmtCreate":1637199210060,"gmtModify":1637199210060,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"Okay ","listText":"Okay ","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/878226325","repostId":"1180752156","repostType":4,"isVote":1,"tweetType":1,"viewCount":1149,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875170061,"gmtCreate":1637628442357,"gmtModify":1637628442357,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/875170061","repostId":"1122322848","repostType":4,"isVote":1,"tweetType":1,"viewCount":2011,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876175969,"gmtCreate":1637286640802,"gmtModify":1637286640802,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876175969","repostId":"1168345410","repostType":4,"isVote":1,"tweetType":1,"viewCount":1366,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873664166,"gmtCreate":1636939001730,"gmtModify":1636939001730,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"Okay!","listText":"Okay!","text":"Okay!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873664166","repostId":"1102708415","repostType":4,"isVote":1,"tweetType":1,"viewCount":1368,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846062060,"gmtCreate":1636035736976,"gmtModify":1636035737046,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"interesting","listText":"interesting","text":"interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/846062060","repostId":"1168874793","repostType":4,"repost":{"id":"1168874793","kind":"news","pubTimestamp":1636035446,"share":"https://www.laohunote.com/m/news/1168874793?lang=zh_CN&edition=full","pubTime":"2021-11-04 22:17","market":"us","language":"en","title":"Ocugen: WHO Approval For Covaxin Is Potentially A Red Herring For Investors<blockquote>Ocugen:世卫组织批准科瓦克辛可能是投资者的转移注意力</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1168874793","media":"Seeking Alpha","summary":"Summary\n\nOcugen missed the opportunity to grab an Emergency Use Authorization for Covaxin in the US ","content":"<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul> <li>Ocugen missed the opportunity to grab an Emergency Use Authorization for Covaxin in the US earlier this year, but it could still gain an approval via a pivotal immuno-bridging study.</li> <li>Meanwhile, Bharat has received WHO approval for Emergency Use Listing, meaning the vaccine can be distributed around the world - but that doesn't directly benefit Ocugen.</li> <li>There are numerous possibilities in play, and Ocugen has no shortage of backers and shorts - the stock is up >4,000% in the past year, but has trodden water for several months.</li> <li>It's hard to determine what may be in store next for Ocugen shareholders, but if I were one, I'd be holding and hoping. I recap the full story below.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/25648bf13e5cb82880f748129c72261c\" tg-width=\"1536\" tg-height=\"1024\" width=\"100%\" height=\"auto\"><span>Klaus Vedfelt/DigitalVision via Getty Images</span></p><p><blockquote><ul><li>今年早些时候,Ocugen错过了在美国获得科瓦克辛紧急使用授权的机会,但它仍然可以通过一项关键的免疫桥接研究获得批准。</li><li>与此同时,Bharat 已获得世卫组织紧急使用清单批准,这意味着该疫苗可以在世界各地分发,但这并没有直接使 Ocugen 受益。</li><li>有许多可能性在发挥作用,Ocugen 并不缺乏支持者和空头 - 该股在过去一年中上涨了 4,000% 以上,但几个月来一直在下跌。</li><li>很难确定 Ocugen 股东接下来会发生什么,但如果我是其中之一,我会持有并希望。我在下面回顾一下整个故事。</li></ul><p class=\"t-img-caption\"><span>Klaus Vedfelt/数字视觉,盖蒂图片社</span></p></blockquote></p><p> <b>Investment Thesis</b></p><p><blockquote><b>投资论文</b></blockquote></p><p> Bharat Biotech received an approval from the World Health Organization (\"WHO\") today to join the Emergency Use List (\"EUL\") for vaccines against COVID-19.</p><p><blockquote>巴拉特生物技术公司今天获得世界卫生组织(“世卫组织”)的批准,加入新冠肺炎疫苗的紧急使用清单(“EUL”)。</blockquote></p><p> As most investors will know, Ocugen (OCGN) holds the rights to distribute Covaxin in the US on behalf of Bharat, in exchange for a 45% share of all profits. It also has a similar deal in place for Canada, standing to earn 55% of all profits.</p><p><blockquote>大多数投资者都知道,Ocugen (OCGN) 拥有代表 Bharat 在美国分销科瓦克辛的权利,以换取所有利润的 45% 份额。它在加拿大也有类似的交易,有望获得所有利润的55%。</blockquote></p><p> Ocugen investors and shorts will be nervously waiting to see how today's news affects the biotech's share price, which initially jumped to $16, but has fallen to $12 post-market.</p><p><blockquote>Ocugen 投资者和空头将紧张地等待今天的消息将如何影响这家生物技术公司的股价,该公司的股价最初跃升至 16 美元,但盘后已跌至 12 美元。</blockquote></p><p> In this post I recap the full story, updated from my last post in June, and offer some ways to think about Ocugen's share price in the short and long term.</p><p><blockquote>在这篇文章中,我回顾了我六月份上一篇文章更新的完整故事,并提供了一些短期和长期思考 Ocugen 股价的方法。</blockquote></p><p> <b>Ocugen Stock Jumps From $0.5 To $16 In 3 Months On Bharat COVID Vaccine Deal - The Story So Far</b></p><p><blockquote><b>由于 Bharat COVID 疫苗交易,Ocugen 股价在 3 个月内从 0.5 美元跃升至 16 美元 - 迄今为止的故事</b></blockquote></p><p> Ocugen is one of the more bizarre biotech stories of 2021. In mid-December 2020, its shares were trading <$0.5, as the company struggled to develop a preclinical portfolio of gene therapy drug candidates targeting eye disease, having abandoned development of its lead candidate OCU300 in Graft vs Host Disease (\"GvHD\").</p><p><blockquote>Ocugen是2021年更离奇的生物技术故事之一。2020 年 12 月中旬,其股价低于 0.5 美元,因为该公司正在努力开发针对眼部疾病的基因治疗候选药物的临床前组合,放弃了移植物抗宿主病的主要候选药物 OCU300 的开发(“GvHD”)。</blockquote></p><p> A delisting from the Nasdaq looked a likely outcome for the company, but then Ocugen's fortunes changed dramatically - the biotech became a partner of Bharat Biotech, developer of the whole-virion inactivated vaccine candidate Covaxin, agreeing to help the Indian Pharma commercialise Covaxin in the US and Canada. Overnight, Ocugen's share price jumped to a price of $3, and by early February, it was trading at $16.</p><p><blockquote>从纳斯达克退市看起来是该公司可能的结果,但随后 Ocugen 的命运发生了巨大变化——该生物技术公司成为全病毒体灭活疫苗候选药物 Covaxin 的开发商 Bharat Biotech 的合作伙伴,同意帮助印度制药公司将 Covaxin 商业化在美国和加拿大。一夜之间,Ocugen 的股价跃升至 3 美元,到 2 月初,其交易价格为 16 美元。</blockquote></p><p> I covered the full story in a note on Ocugen back in June, when Ocugen's shares were trading in a slightly more down-to-earth range of $6 - $10. At that time, the key question was whether Covaxin would receive an Emergency Use Authorization (\"EUA\") from the FDA, allowing it to be marketed and sold in the US.</p><p><blockquote>早在 6 月份,我就在 Ocugen 的一篇笔记中讲述了整个故事,当时 Ocugen 的股价在 6 美元至 10 美元的范围内稍微实在一些。当时的关键问题是科瓦克辛是否会获得FDA的紧急使用授权(“EUA”),允许其在美国上市销售。</blockquote></p><p> Unfortunately for Ocugen investors, delays in Bharat's trials of Covaxin in India, where outbreaks of COVID had suddenly become widespread, meant that Ocugen could not get positive Phase 3 trial data in front of the FDA in time for a deadline imposed by the US government - after which it would not accept any further EUA requests for COVID-19 vaccines for the remainder of the pandemic for those companies that have not already begun discussions with the FDA.</p><p><blockquote>对于 Ocugen 投资者来说不幸的是,Bharat 在印度进行的科瓦克辛试验的延误意味着 Ocugen 无法在美国政府规定的最后期限前及时向 FDA 获得积极的 3 期试验数据 - 此后,对于那些尚未开始与 FDA 讨论的公司,它将不再接受任何进一步的 EUA 请求。</blockquote></p><p> <b>Ocugen And Bharat Stay The Course - Trials Reveal Strong Efficacy</b></p><p><blockquote><b>Ocugen 和 Bharat 坚持到底 - 试验显示强效疗效</b></blockquote></p><p> The bad news about an EUA in the US did not deter Ocugen, Bharat, or Ocugen's investors, however. Despite heavy short interest, as many market watchers concluded Ocugen's share price would be decimated without an EUA for Covaxin in the US, Ocugen management felt that there were other options on the table, including obtaining an EUA in Canada, which falls under its agreement with Bharat, allowing Ocugen to earn 45% of all revenues earned in the region.</p><p><blockquote>然而,有关美国EUA的坏消息并没有阻止Ocugen、Bharat或Ocugen的投资者。尽管空头兴趣浓厚,但许多市场观察人士得出结论,如果没有美国科瓦克辛的 EUA,Ocugen 的股价将会大幅下跌,Ocugen 管理层认为还有其他选择,包括在加拿大获得 EUA,这属于其与 Bharat 的协议范围,使 Ocugen 能够赚取该地区所有收入的 45%。</blockquote></p><p> The results of Bharat's ~@5k patient Phase 3 trial in India also came out positive.</p><p><blockquote>Bharat在印度的~@5k患者3期试验结果也呈阳性。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/862520ed53c876fb96840a3cb9a7a6f9\" tg-width=\"640\" tg-height=\"317\" width=\"100%\" height=\"auto\"><span>Summary of results of Bharat Biotech Phase 3 trial of Covaxin. Source: Ocugen Corporate Presentation.</span></p><p><blockquote><p class=\"t-img-caption\"><span>Bharat Biotech科瓦克辛3期试验结果总结。资料来源:Ocugen公司演示文稿。</span></p></blockquote></p><p> As we can see above, Bharat's Covaxin (finally) delivered an efficacy readout of 77.8%, 93.4% efficacy against severe disease - and 65.2% efficacy against the delta variant - the most devastating of all the COVID strains. Furthermore, the National Institute of Allergies and Infectious Diseases advised that a novel vaccine adjuvant developed in Kansas, US with NIAID support, Alhydroxiquim-II, enhanced the overall efficacy of Covaxin.</p><p><blockquote>正如我们在上面看到的,巴拉特的科瓦克辛(最终)提供了77.8%的功效读数,对严重疾病的功效为93.4%,对德尔塔变异毒株的功效为65.2%,是所有新冠病毒毒株中最具破坏性的。此外,美国国家过敏和传染病研究所建议,在NIAID支持下,美国堪萨斯州开发的一种新型疫苗佐剂Alhydroxiquim-II增强了科瓦克辛的总体疗效。</blockquote></p><p> <b>Bharat Pursues WHO Emergency Use Listing Whilst Ocugen Looks To Canada</b></p><p><blockquote><b>Bharat 寻求世卫组织紧急使用清单,而 Ocugen 则将目光投向加拿大</b></blockquote></p><p></p><p> These results, as strong as they are - and it should be noted the efficacy of Pfizer (PFE) and BioNTech's (BNTX) messenger-RNA Comirnaty vaccine against the Delta variant has dropped as low as 39% in studies in Israel - they arrived too late to help Ocugen secure an EUA in the US.</p><p><blockquote>这些结果尽管很有力——应该指出的是,辉瑞 (PFE) 和 BioNTech (BNTX) 信使 RNA Comirnaty 疫苗对德尔塔变异毒株病毒的效力在以色列的研究中已降至 39%——但它们来得太晚了,无法帮助 Ocugen 在美国获得 EUA。</blockquote></p><p> Ocugen turned its attention to Canada,announcing a rolling submission to Health Canada on July 15 through its affiliate, Vaccigen, Ltd<b>,</b>allowing for it to submit new data as and when it came in, accelerating the overall review process.</p><p><blockquote>Ocugen 将注意力转向加拿大,宣布于 7 月 15 日通过其附属公司 Vaccigen, Ltd. 向加拿大卫生部提交滚动申请<b>,</b>允许it在收到新数据时提交新数据,从而加快整体审查流程。</blockquote></p><p> If approved, Ocugen will earn 55% of all profits earned from the vaccine, but as I discussed in my last note when providing some discounted cash flow analysis based on optimistic and pessimistic scenarios, it's doubtful if the Canadian government's purchases alone would provide a significant boot to Ocugen's current market cap valuation of $2.5bn, or its share price of $12.7.</p><p><blockquote>如果获得批准,Ocugen 将获得疫苗所有利润的 55%,但正如我在上一篇文章中根据乐观和悲观情景提供一些贴现现金流分析时所讨论的那样,加拿大政府的采购是否会对 Ocugen 目前的市值估值 25 亿美元,或其股价 12.7 美元,这一点值得怀疑。</blockquote></p><p> The US is the key for Ocugen, and management has by no means given up on this opportunity. In late October, Ocugen made an Investigational New Drug (\"IND\") submission to the FDA. Ocugen's plan is to initiate a Phase 3 \"immuno-bridging study,\" enrolling several hundred healthy adults in the U.S, who will receive 2 doses of Covaxin or placebo, 28 days apart. The endpoints are described by management (in an October 27th press release) as follows:</p><p><blockquote>美国是Ocugen的关键,管理层绝不会放弃这个机会。10月下旬,Ocugen向FDA提交了研究性新药(“IND”)。Ocugen 的计划是启动一项 3 期“免疫桥接研究”,在美国招募数百名健康成年人,他们将接受 2 剂科瓦克辛或安慰剂,间隔 28 天。管理层(在 10 月 27 日的新闻稿中)对终点进行了如下描述:</blockquote></p><p> The primary endpoint will compare blood-based samples taken from U.S. participants who received COVAXIN™ with samples of the participants in the Phase 3 efficacy trial conducted in India. The secondary endpoint involves testing the vaccine's immunogenic profile. The study will also evaluate safety and tolerability in the U.S. population. Ocugen hopes to have the study complete before the end of H122, if it is approved by the FDA, which has yet to make a decision. If the FDA does give the green light, then the US market - and Ocugen's 45% of all profits - is suddenly back on the table.</p><p><blockquote>主要终点将比较从接受科瓦克辛的美国参与者身上采集的血液样本™在印度进行的3期疗效试验的参与者样本。次要终点包括测试疫苗的免疫原性特征。该研究还将评估美国人群的安全性和耐受性。Ocugen希望在H122结束前完成研究,如果获得FDA的批准,FDA尚未做出决定。如果 FDA 确实开了绿灯,那么美国市场——以及 Ocugen 所有利润的 45%——就会突然回到桌面上。</blockquote></p><p> Meanwhile, Bharat Biotech received notification today that the World Health Organization has approved its application for an Emergency Use Listing (\"EUL\"), meaning Covaxin will now likely be accepted by a host of foreign governments, and that Indians who have received the vaccine will have fewer problems traveling overseas.</p><p><blockquote>与此同时,Bharat Biotech今天收到通知,世界卫生组织已经批准了其紧急使用清单(“EUL”)的申请,这意味着科瓦克辛现在可能会被许多外国政府接受,接种疫苗的印度人出国旅行将减少问题。</blockquote></p><p> It's great news for Bharat, who join the likes of Pfizer / BioNTech, Johnson & Johnson (JNJ), SinoPharm, Moderna (MRNA) and AstraZeneca (AZN) on the list of EUL-approved vaccine developers - but it is not necessarily great news for Ocugen.</p><p><blockquote>这对Bharat来说是个好消息,他加入了辉瑞/BioNTech、强生(JNJ)、国药集团、Moderna(MRNA)和阿斯利康(AZN)等公司的行列,成为EUL批准的疫苗开发商,但对Ocugen来说不一定是个好消息。</blockquote></p><p> Vaccines on the EUL list are permitted to be sent to government's around the world as part of the COVAX scheme, designed to create equitable vaccine distribution around the world, including poorer countries, but the US is a donor to this scheme, not a beneficiary, meaning that Ocugen effectively gets no benefit, and no revenues, as a result of the WHO approval for Covaxin.</p><p><blockquote>作为COVAX计划的一部分,EUL名单上的疫苗被允许发送到世界各地的政府,该计划旨在在世界各地(包括较贫穷的国家)建立公平的疫苗分配,但美国是该计划的捐助者,而不是受益者,这意味着由于世卫组织批准科瓦克辛,Ocugen实际上没有获得任何好处和收入。</blockquote></p><p> <b>Ocugen Stock Is Already On A Downtrend - All Eyes Will Now Be On Health Canada And The FDA</b></p><p><blockquote><b>Ocugen 股票已经处于下跌趋势 - 现在所有的目光都将集中在加拿大卫生部和 FDA 上</b></blockquote></p><p> Ocugen stock bounced from a price of ~$9, to a peak of ~$16 in trading today, however the share price quickly began to decline, and finished at a price of $12.7. Post-market, shares were down another 10%.</p><p><blockquote>Ocugen 股票在今天的交易中从约 9 美元的价格反弹至约 16 美元的峰值,但股价很快开始下跌,最终以 12.7 美元的价格收盘。盘后,股价又下跌10%。</blockquote></p><p> That reflects the fact that the WHO approval for Covaxin does little to improve Ocugen's own fortunes, and in all honesty, was something of a red herring.</p><p><blockquote>这反映了这样一个事实,即世卫组织对科瓦克辛的批准对改善奥库根自己的命运没有什么帮助,老实说,这是一种转移视线。</blockquote></p><p> Ocugen investors, and Ocugen shorts, are desperate to know what the future holds for Covaxin in the US and Canada, but they will have to wait until Health Canada and the FDA rule respectively on an Emergency Use Authorization, and an approval to begin a drastically reduced pivotal trial in the US.</p><p><blockquote>Ocugen 投资者和 Ocugen shorts 迫切希望知道科瓦克辛在美国和加拿大的未来,但他们必须等到加拿大卫生部和 FDA 分别就紧急使用授权做出裁决,并批准在美国开始一项大幅减少的关键试验。</blockquote></p><p> Ironically, despite all of the news flow and the publication of Covaxin Phase 3 trial data, and the EUA granted to Covaxin by the Indian government, Ocugen's fortunes are in a similar place to where they were when I last covered the company - barring the US EUA opportunity.</p><p><blockquote>具有讽刺意味的是,尽管有所有的新闻流和科瓦克辛3期试验数据的公布,以及印度政府授予科瓦克辛的EUA,Ocugen的命运与我上次报道该公司时的情况相似——除了美国的EUA机会。</blockquote></p><p> That opportunity - the one that may have sent Ocugen shares through the roof - has gone, but as I argued in my last post, I think it's possible that the US would not object to stockpiling some of the Covaxin shot, which has a differentiated mechanism of action, and a shelf life of up to years if stored at 2- 8 degrees centigrade.</p><p><blockquote>这个机会——可能会让 Ocugen 股票暴跌的机会——已经一去不复返了,但正如我在上一篇文章中所说,我认为美国可能不会反对储备一些科瓦克辛子弹,它具有不同的作用机制,如果储存在 2-8 摄氏度下,保质期可达数年。</blockquote></p><p> Covaxin may have benefits that other vaccines do not, the reasoning may go, such as its ability to induce a Th1 response, conferring cell-mediated immunity and offering durable protection, and enhanced protection against COVID variants, which is the primary concern at the present time.</p><p><blockquote>科瓦克辛可能具有其他疫苗没有的好处,理由可能是这样的,例如它能够诱导Th1反应,赋予细胞介导的免疫并提供持久的保护,以及增强对COVID变种的保护,这是目前的主要问题。</blockquote></p><p> On the other hand, the US may now be able to obtain supply directly from Bharat via the WHO and be in a position to cut Ocugen - the middleman - out of any deal.</p><p><blockquote>另一方面,美国现在可能能够通过世卫组织直接从巴拉特获得供应,并能够将中间人Ocugen排除在任何交易之外。</blockquote></p><p></p><p> The fact of the matter is that Ocugen's opportunity with Bharat and Covaxin has always appeared to be one that required expediency of execution, in order to capitalize on a US market opportunity that's uncertain, perhaps negligible, at worst, and a potential multi-billion opportunity at best.</p><p><blockquote>事实是,Ocugen与巴拉特和科瓦克辛的机会似乎总是需要执行权宜之计,以便利用美国市场的机会,这个机会在最坏的情况下是不确定的,也许可以忽略不计,在最好的情况下是潜在的数十亿美元的机会。</blockquote></p><p> Nobody knows even if Ocugen will get an opportunity to market Covaxin in the US, but if it does, it will need to negotiate a tricky Phase 3 trial first, which could take us into the latter half of next year. Equally, no-one yet knows if Health Canada will approve the vaccine.</p><p><blockquote>甚至没有人知道 Ocugen 是否会有机会在美国销售科瓦克辛,但如果有机会,它将需要首先谈判一项棘手的 3 期试验,这可能会让我们进入明年下半年。同样,还没有人知道加拿大卫生部是否会批准这种疫苗。</blockquote></p><p> <b>Conclusion</b></p><p><blockquote><b>结论</b></blockquote></p><p> To summarise the current state of affairs, I would lean toward an approval in Canada - if Covaxin is good enough for the WHO, why would it not be good enough for Canada?</p><p><blockquote>总结目前的情况,我倾向于加拿大的批准——如果科瓦克辛对世卫组织来说足够好,为什么对加拿大来说就不够好呢?</blockquote></p><p> But how much product will Canada buy? Probably enough to create a substantial price spike for Ocugen stock, although demand is unlikely to be high enough to sustain that spike long term.</p><p><blockquote>但是加拿大会购买多少产品呢?可能足以给 Ocugen 股票带来大幅价格飙升,尽管需求不太可能高到足以长期维持这种飙升。</blockquote></p><p> How much would the US buy if Covaxin was approved in the US? Again, I cannot see it being a high enough volume to catapult Ocugen's market cap above say $10bn, but if it buys any at all, Ocugen's market valuation is more or less guaranteed to surge, at least temporarily.</p><p><blockquote>如果科瓦克辛在美国获得批准,美国会购买多少?同样,我认为这个交易量不足以让 Ocugen 的市值突破 100 亿美元,但如果它购买任何股票,Ocugen 的市场估值或多或少肯定会飙升,至少是暂时的。</blockquote></p><p> In conclusion, I would argue that there is enough intrigue and opportunity in the Ocugen story to keep investors interested - on both the short and long sides. The WHO approval does not directly benefit Ocugen revenues wise, but it's another win for Covaxin, which is in turn a win for Ocugen.</p><p><blockquote>总之,我认为 Ocugen 的故事中有足够的阴谋和机会来保持投资者的兴趣——无论是空头还是多头。世卫组织的批准并没有直接有利于 Ocugen 的收入,但这是科瓦克辛的又一次胜利,而这反过来又是 Ocugen 的胜利。</blockquote></p><p> If I has been holding Ocugen stock since December last year, when it traded at >$0.5, frankly I would have sold by now, but if I had opened a position at ~$10, in expectation of doubling my money on a US approval, I would still be (nervously) holding.</p><p><blockquote>如果我自去年 12 月以来一直持有 Ocugen 股票,当时它的交易价格超过 0.5 美元,坦率地说,我现在已经卖出了,但如果我以约 10 美元的价格开仓,预计在美国批准后将资金翻倍,我仍然会(紧张地)持有。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen: WHO Approval For Covaxin Is Potentially A Red Herring For Investors<blockquote>Ocugen:世卫组织批准科瓦克辛可能是投资者的转移注意力</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen: WHO Approval For Covaxin Is Potentially A Red Herring For Investors<blockquote>Ocugen:世卫组织批准科瓦克辛可能是投资者的转移注意力</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-11-04 22:17</span>\n</p>\n</h4>\n</header>\n<article>\n<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul> <li>Ocugen missed the opportunity to grab an Emergency Use Authorization for Covaxin in the US earlier this year, but it could still gain an approval via a pivotal immuno-bridging study.</li> <li>Meanwhile, Bharat has received WHO approval for Emergency Use Listing, meaning the vaccine can be distributed around the world - but that doesn't directly benefit Ocugen.</li> <li>There are numerous possibilities in play, and Ocugen has no shortage of backers and shorts - the stock is up >4,000% in the past year, but has trodden water for several months.</li> <li>It's hard to determine what may be in store next for Ocugen shareholders, but if I were one, I'd be holding and hoping. I recap the full story below.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/25648bf13e5cb82880f748129c72261c\" tg-width=\"1536\" tg-height=\"1024\" width=\"100%\" height=\"auto\"><span>Klaus Vedfelt/DigitalVision via Getty Images</span></p><p><blockquote><ul><li>今年早些时候,Ocugen错过了在美国获得科瓦克辛紧急使用授权的机会,但它仍然可以通过一项关键的免疫桥接研究获得批准。</li><li>与此同时,Bharat 已获得世卫组织紧急使用清单批准,这意味着该疫苗可以在世界各地分发,但这并没有直接使 Ocugen 受益。</li><li>有许多可能性在发挥作用,Ocugen 并不缺乏支持者和空头 - 该股在过去一年中上涨了 4,000% 以上,但几个月来一直在下跌。</li><li>很难确定 Ocugen 股东接下来会发生什么,但如果我是其中之一,我会持有并希望。我在下面回顾一下整个故事。</li></ul><p class=\"t-img-caption\"><span>Klaus Vedfelt/数字视觉,盖蒂图片社</span></p></blockquote></p><p> <b>Investment Thesis</b></p><p><blockquote><b>投资论文</b></blockquote></p><p> Bharat Biotech received an approval from the World Health Organization (\"WHO\") today to join the Emergency Use List (\"EUL\") for vaccines against COVID-19.</p><p><blockquote>巴拉特生物技术公司今天获得世界卫生组织(“世卫组织”)的批准,加入新冠肺炎疫苗的紧急使用清单(“EUL”)。</blockquote></p><p> As most investors will know, Ocugen (OCGN) holds the rights to distribute Covaxin in the US on behalf of Bharat, in exchange for a 45% share of all profits. It also has a similar deal in place for Canada, standing to earn 55% of all profits.</p><p><blockquote>大多数投资者都知道,Ocugen (OCGN) 拥有代表 Bharat 在美国分销科瓦克辛的权利,以换取所有利润的 45% 份额。它在加拿大也有类似的交易,有望获得所有利润的55%。</blockquote></p><p> Ocugen investors and shorts will be nervously waiting to see how today's news affects the biotech's share price, which initially jumped to $16, but has fallen to $12 post-market.</p><p><blockquote>Ocugen 投资者和空头将紧张地等待今天的消息将如何影响这家生物技术公司的股价,该公司的股价最初跃升至 16 美元,但盘后已跌至 12 美元。</blockquote></p><p> In this post I recap the full story, updated from my last post in June, and offer some ways to think about Ocugen's share price in the short and long term.</p><p><blockquote>在这篇文章中,我回顾了我六月份上一篇文章更新的完整故事,并提供了一些短期和长期思考 Ocugen 股价的方法。</blockquote></p><p> <b>Ocugen Stock Jumps From $0.5 To $16 In 3 Months On Bharat COVID Vaccine Deal - The Story So Far</b></p><p><blockquote><b>由于 Bharat COVID 疫苗交易,Ocugen 股价在 3 个月内从 0.5 美元跃升至 16 美元 - 迄今为止的故事</b></blockquote></p><p> Ocugen is one of the more bizarre biotech stories of 2021. In mid-December 2020, its shares were trading <$0.5, as the company struggled to develop a preclinical portfolio of gene therapy drug candidates targeting eye disease, having abandoned development of its lead candidate OCU300 in Graft vs Host Disease (\"GvHD\").</p><p><blockquote>Ocugen是2021年更离奇的生物技术故事之一。2020 年 12 月中旬,其股价低于 0.5 美元,因为该公司正在努力开发针对眼部疾病的基因治疗候选药物的临床前组合,放弃了移植物抗宿主病的主要候选药物 OCU300 的开发(“GvHD”)。</blockquote></p><p> A delisting from the Nasdaq looked a likely outcome for the company, but then Ocugen's fortunes changed dramatically - the biotech became a partner of Bharat Biotech, developer of the whole-virion inactivated vaccine candidate Covaxin, agreeing to help the Indian Pharma commercialise Covaxin in the US and Canada. Overnight, Ocugen's share price jumped to a price of $3, and by early February, it was trading at $16.</p><p><blockquote>从纳斯达克退市看起来是该公司可能的结果,但随后 Ocugen 的命运发生了巨大变化——该生物技术公司成为全病毒体灭活疫苗候选药物 Covaxin 的开发商 Bharat Biotech 的合作伙伴,同意帮助印度制药公司将 Covaxin 商业化在美国和加拿大。一夜之间,Ocugen 的股价跃升至 3 美元,到 2 月初,其交易价格为 16 美元。</blockquote></p><p> I covered the full story in a note on Ocugen back in June, when Ocugen's shares were trading in a slightly more down-to-earth range of $6 - $10. At that time, the key question was whether Covaxin would receive an Emergency Use Authorization (\"EUA\") from the FDA, allowing it to be marketed and sold in the US.</p><p><blockquote>早在 6 月份,我就在 Ocugen 的一篇笔记中讲述了整个故事,当时 Ocugen 的股价在 6 美元至 10 美元的范围内稍微实在一些。当时的关键问题是科瓦克辛是否会获得FDA的紧急使用授权(“EUA”),允许其在美国上市销售。</blockquote></p><p> Unfortunately for Ocugen investors, delays in Bharat's trials of Covaxin in India, where outbreaks of COVID had suddenly become widespread, meant that Ocugen could not get positive Phase 3 trial data in front of the FDA in time for a deadline imposed by the US government - after which it would not accept any further EUA requests for COVID-19 vaccines for the remainder of the pandemic for those companies that have not already begun discussions with the FDA.</p><p><blockquote>对于 Ocugen 投资者来说不幸的是,Bharat 在印度进行的科瓦克辛试验的延误意味着 Ocugen 无法在美国政府规定的最后期限前及时向 FDA 获得积极的 3 期试验数据 - 此后,对于那些尚未开始与 FDA 讨论的公司,它将不再接受任何进一步的 EUA 请求。</blockquote></p><p> <b>Ocugen And Bharat Stay The Course - Trials Reveal Strong Efficacy</b></p><p><blockquote><b>Ocugen 和 Bharat 坚持到底 - 试验显示强效疗效</b></blockquote></p><p> The bad news about an EUA in the US did not deter Ocugen, Bharat, or Ocugen's investors, however. Despite heavy short interest, as many market watchers concluded Ocugen's share price would be decimated without an EUA for Covaxin in the US, Ocugen management felt that there were other options on the table, including obtaining an EUA in Canada, which falls under its agreement with Bharat, allowing Ocugen to earn 45% of all revenues earned in the region.</p><p><blockquote>然而,有关美国EUA的坏消息并没有阻止Ocugen、Bharat或Ocugen的投资者。尽管空头兴趣浓厚,但许多市场观察人士得出结论,如果没有美国科瓦克辛的 EUA,Ocugen 的股价将会大幅下跌,Ocugen 管理层认为还有其他选择,包括在加拿大获得 EUA,这属于其与 Bharat 的协议范围,使 Ocugen 能够赚取该地区所有收入的 45%。</blockquote></p><p> The results of Bharat's ~@5k patient Phase 3 trial in India also came out positive.</p><p><blockquote>Bharat在印度的~@5k患者3期试验结果也呈阳性。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/862520ed53c876fb96840a3cb9a7a6f9\" tg-width=\"640\" tg-height=\"317\" width=\"100%\" height=\"auto\"><span>Summary of results of Bharat Biotech Phase 3 trial of Covaxin. Source: Ocugen Corporate Presentation.</span></p><p><blockquote><p class=\"t-img-caption\"><span>Bharat Biotech科瓦克辛3期试验结果总结。资料来源:Ocugen公司演示文稿。</span></p></blockquote></p><p> As we can see above, Bharat's Covaxin (finally) delivered an efficacy readout of 77.8%, 93.4% efficacy against severe disease - and 65.2% efficacy against the delta variant - the most devastating of all the COVID strains. Furthermore, the National Institute of Allergies and Infectious Diseases advised that a novel vaccine adjuvant developed in Kansas, US with NIAID support, Alhydroxiquim-II, enhanced the overall efficacy of Covaxin.</p><p><blockquote>正如我们在上面看到的,巴拉特的科瓦克辛(最终)提供了77.8%的功效读数,对严重疾病的功效为93.4%,对德尔塔变异毒株的功效为65.2%,是所有新冠病毒毒株中最具破坏性的。此外,美国国家过敏和传染病研究所建议,在NIAID支持下,美国堪萨斯州开发的一种新型疫苗佐剂Alhydroxiquim-II增强了科瓦克辛的总体疗效。</blockquote></p><p> <b>Bharat Pursues WHO Emergency Use Listing Whilst Ocugen Looks To Canada</b></p><p><blockquote><b>Bharat 寻求世卫组织紧急使用清单,而 Ocugen 则将目光投向加拿大</b></blockquote></p><p></p><p> These results, as strong as they are - and it should be noted the efficacy of Pfizer (PFE) and BioNTech's (BNTX) messenger-RNA Comirnaty vaccine against the Delta variant has dropped as low as 39% in studies in Israel - they arrived too late to help Ocugen secure an EUA in the US.</p><p><blockquote>这些结果尽管很有力——应该指出的是,辉瑞 (PFE) 和 BioNTech (BNTX) 信使 RNA Comirnaty 疫苗对德尔塔变异毒株病毒的效力在以色列的研究中已降至 39%——但它们来得太晚了,无法帮助 Ocugen 在美国获得 EUA。</blockquote></p><p> Ocugen turned its attention to Canada,announcing a rolling submission to Health Canada on July 15 through its affiliate, Vaccigen, Ltd<b>,</b>allowing for it to submit new data as and when it came in, accelerating the overall review process.</p><p><blockquote>Ocugen 将注意力转向加拿大,宣布于 7 月 15 日通过其附属公司 Vaccigen, Ltd. 向加拿大卫生部提交滚动申请<b>,</b>允许it在收到新数据时提交新数据,从而加快整体审查流程。</blockquote></p><p> If approved, Ocugen will earn 55% of all profits earned from the vaccine, but as I discussed in my last note when providing some discounted cash flow analysis based on optimistic and pessimistic scenarios, it's doubtful if the Canadian government's purchases alone would provide a significant boot to Ocugen's current market cap valuation of $2.5bn, or its share price of $12.7.</p><p><blockquote>如果获得批准,Ocugen 将获得疫苗所有利润的 55%,但正如我在上一篇文章中根据乐观和悲观情景提供一些贴现现金流分析时所讨论的那样,加拿大政府的采购是否会对 Ocugen 目前的市值估值 25 亿美元,或其股价 12.7 美元,这一点值得怀疑。</blockquote></p><p> The US is the key for Ocugen, and management has by no means given up on this opportunity. In late October, Ocugen made an Investigational New Drug (\"IND\") submission to the FDA. Ocugen's plan is to initiate a Phase 3 \"immuno-bridging study,\" enrolling several hundred healthy adults in the U.S, who will receive 2 doses of Covaxin or placebo, 28 days apart. The endpoints are described by management (in an October 27th press release) as follows:</p><p><blockquote>美国是Ocugen的关键,管理层绝不会放弃这个机会。10月下旬,Ocugen向FDA提交了研究性新药(“IND”)。Ocugen 的计划是启动一项 3 期“免疫桥接研究”,在美国招募数百名健康成年人,他们将接受 2 剂科瓦克辛或安慰剂,间隔 28 天。管理层(在 10 月 27 日的新闻稿中)对终点进行了如下描述:</blockquote></p><p> The primary endpoint will compare blood-based samples taken from U.S. participants who received COVAXIN™ with samples of the participants in the Phase 3 efficacy trial conducted in India. The secondary endpoint involves testing the vaccine's immunogenic profile. The study will also evaluate safety and tolerability in the U.S. population. Ocugen hopes to have the study complete before the end of H122, if it is approved by the FDA, which has yet to make a decision. If the FDA does give the green light, then the US market - and Ocugen's 45% of all profits - is suddenly back on the table.</p><p><blockquote>主要终点将比较从接受科瓦克辛的美国参与者身上采集的血液样本™在印度进行的3期疗效试验的参与者样本。次要终点包括测试疫苗的免疫原性特征。该研究还将评估美国人群的安全性和耐受性。Ocugen希望在H122结束前完成研究,如果获得FDA的批准,FDA尚未做出决定。如果 FDA 确实开了绿灯,那么美国市场——以及 Ocugen 所有利润的 45%——就会突然回到桌面上。</blockquote></p><p> Meanwhile, Bharat Biotech received notification today that the World Health Organization has approved its application for an Emergency Use Listing (\"EUL\"), meaning Covaxin will now likely be accepted by a host of foreign governments, and that Indians who have received the vaccine will have fewer problems traveling overseas.</p><p><blockquote>与此同时,Bharat Biotech今天收到通知,世界卫生组织已经批准了其紧急使用清单(“EUL”)的申请,这意味着科瓦克辛现在可能会被许多外国政府接受,接种疫苗的印度人出国旅行将减少问题。</blockquote></p><p> It's great news for Bharat, who join the likes of Pfizer / BioNTech, Johnson & Johnson (JNJ), SinoPharm, Moderna (MRNA) and AstraZeneca (AZN) on the list of EUL-approved vaccine developers - but it is not necessarily great news for Ocugen.</p><p><blockquote>这对Bharat来说是个好消息,他加入了辉瑞/BioNTech、强生(JNJ)、国药集团、Moderna(MRNA)和阿斯利康(AZN)等公司的行列,成为EUL批准的疫苗开发商,但对Ocugen来说不一定是个好消息。</blockquote></p><p> Vaccines on the EUL list are permitted to be sent to government's around the world as part of the COVAX scheme, designed to create equitable vaccine distribution around the world, including poorer countries, but the US is a donor to this scheme, not a beneficiary, meaning that Ocugen effectively gets no benefit, and no revenues, as a result of the WHO approval for Covaxin.</p><p><blockquote>作为COVAX计划的一部分,EUL名单上的疫苗被允许发送到世界各地的政府,该计划旨在在世界各地(包括较贫穷的国家)建立公平的疫苗分配,但美国是该计划的捐助者,而不是受益者,这意味着由于世卫组织批准科瓦克辛,Ocugen实际上没有获得任何好处和收入。</blockquote></p><p> <b>Ocugen Stock Is Already On A Downtrend - All Eyes Will Now Be On Health Canada And The FDA</b></p><p><blockquote><b>Ocugen 股票已经处于下跌趋势 - 现在所有的目光都将集中在加拿大卫生部和 FDA 上</b></blockquote></p><p> Ocugen stock bounced from a price of ~$9, to a peak of ~$16 in trading today, however the share price quickly began to decline, and finished at a price of $12.7. Post-market, shares were down another 10%.</p><p><blockquote>Ocugen 股票在今天的交易中从约 9 美元的价格反弹至约 16 美元的峰值,但股价很快开始下跌,最终以 12.7 美元的价格收盘。盘后,股价又下跌10%。</blockquote></p><p> That reflects the fact that the WHO approval for Covaxin does little to improve Ocugen's own fortunes, and in all honesty, was something of a red herring.</p><p><blockquote>这反映了这样一个事实,即世卫组织对科瓦克辛的批准对改善奥库根自己的命运没有什么帮助,老实说,这是一种转移视线。</blockquote></p><p> Ocugen investors, and Ocugen shorts, are desperate to know what the future holds for Covaxin in the US and Canada, but they will have to wait until Health Canada and the FDA rule respectively on an Emergency Use Authorization, and an approval to begin a drastically reduced pivotal trial in the US.</p><p><blockquote>Ocugen 投资者和 Ocugen shorts 迫切希望知道科瓦克辛在美国和加拿大的未来,但他们必须等到加拿大卫生部和 FDA 分别就紧急使用授权做出裁决,并批准在美国开始一项大幅减少的关键试验。</blockquote></p><p> Ironically, despite all of the news flow and the publication of Covaxin Phase 3 trial data, and the EUA granted to Covaxin by the Indian government, Ocugen's fortunes are in a similar place to where they were when I last covered the company - barring the US EUA opportunity.</p><p><blockquote>具有讽刺意味的是,尽管有所有的新闻流和科瓦克辛3期试验数据的公布,以及印度政府授予科瓦克辛的EUA,Ocugen的命运与我上次报道该公司时的情况相似——除了美国的EUA机会。</blockquote></p><p> That opportunity - the one that may have sent Ocugen shares through the roof - has gone, but as I argued in my last post, I think it's possible that the US would not object to stockpiling some of the Covaxin shot, which has a differentiated mechanism of action, and a shelf life of up to years if stored at 2- 8 degrees centigrade.</p><p><blockquote>这个机会——可能会让 Ocugen 股票暴跌的机会——已经一去不复返了,但正如我在上一篇文章中所说,我认为美国可能不会反对储备一些科瓦克辛子弹,它具有不同的作用机制,如果储存在 2-8 摄氏度下,保质期可达数年。</blockquote></p><p> Covaxin may have benefits that other vaccines do not, the reasoning may go, such as its ability to induce a Th1 response, conferring cell-mediated immunity and offering durable protection, and enhanced protection against COVID variants, which is the primary concern at the present time.</p><p><blockquote>科瓦克辛可能具有其他疫苗没有的好处,理由可能是这样的,例如它能够诱导Th1反应,赋予细胞介导的免疫并提供持久的保护,以及增强对COVID变种的保护,这是目前的主要问题。</blockquote></p><p> On the other hand, the US may now be able to obtain supply directly from Bharat via the WHO and be in a position to cut Ocugen - the middleman - out of any deal.</p><p><blockquote>另一方面,美国现在可能能够通过世卫组织直接从巴拉特获得供应,并能够将中间人Ocugen排除在任何交易之外。</blockquote></p><p></p><p> The fact of the matter is that Ocugen's opportunity with Bharat and Covaxin has always appeared to be one that required expediency of execution, in order to capitalize on a US market opportunity that's uncertain, perhaps negligible, at worst, and a potential multi-billion opportunity at best.</p><p><blockquote>事实是,Ocugen与巴拉特和科瓦克辛的机会似乎总是需要执行权宜之计,以便利用美国市场的机会,这个机会在最坏的情况下是不确定的,也许可以忽略不计,在最好的情况下是潜在的数十亿美元的机会。</blockquote></p><p> Nobody knows even if Ocugen will get an opportunity to market Covaxin in the US, but if it does, it will need to negotiate a tricky Phase 3 trial first, which could take us into the latter half of next year. Equally, no-one yet knows if Health Canada will approve the vaccine.</p><p><blockquote>甚至没有人知道 Ocugen 是否会有机会在美国销售科瓦克辛,但如果有机会,它将需要首先谈判一项棘手的 3 期试验,这可能会让我们进入明年下半年。同样,还没有人知道加拿大卫生部是否会批准这种疫苗。</blockquote></p><p> <b>Conclusion</b></p><p><blockquote><b>结论</b></blockquote></p><p> To summarise the current state of affairs, I would lean toward an approval in Canada - if Covaxin is good enough for the WHO, why would it not be good enough for Canada?</p><p><blockquote>总结目前的情况,我倾向于加拿大的批准——如果科瓦克辛对世卫组织来说足够好,为什么对加拿大来说就不够好呢?</blockquote></p><p> But how much product will Canada buy? Probably enough to create a substantial price spike for Ocugen stock, although demand is unlikely to be high enough to sustain that spike long term.</p><p><blockquote>但是加拿大会购买多少产品呢?可能足以给 Ocugen 股票带来大幅价格飙升,尽管需求不太可能高到足以长期维持这种飙升。</blockquote></p><p> How much would the US buy if Covaxin was approved in the US? Again, I cannot see it being a high enough volume to catapult Ocugen's market cap above say $10bn, but if it buys any at all, Ocugen's market valuation is more or less guaranteed to surge, at least temporarily.</p><p><blockquote>如果科瓦克辛在美国获得批准,美国会购买多少?同样,我认为这个交易量不足以让 Ocugen 的市值突破 100 亿美元,但如果它购买任何股票,Ocugen 的市场估值或多或少肯定会飙升,至少是暂时的。</blockquote></p><p> In conclusion, I would argue that there is enough intrigue and opportunity in the Ocugen story to keep investors interested - on both the short and long sides. The WHO approval does not directly benefit Ocugen revenues wise, but it's another win for Covaxin, which is in turn a win for Ocugen.</p><p><blockquote>总之,我认为 Ocugen 的故事中有足够的阴谋和机会来保持投资者的兴趣——无论是空头还是多头。世卫组织的批准并没有直接有利于 Ocugen 的收入,但这是科瓦克辛的又一次胜利,而这反过来又是 Ocugen 的胜利。</blockquote></p><p> If I has been holding Ocugen stock since December last year, when it traded at >$0.5, frankly I would have sold by now, but if I had opened a position at ~$10, in expectation of doubling my money on a US approval, I would still be (nervously) holding.</p><p><blockquote>如果我自去年 12 月以来一直持有 Ocugen 股票,当时它的交易价格超过 0.5 美元,坦率地说,我现在已经卖出了,但如果我以约 10 美元的价格开仓,预计在美国批准后将资金翻倍,我仍然会(紧张地)持有。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://seekingalpha.com/article/4465154-ocugen-approval-for-covaxin-red-herring-for-investors\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://seekingalpha.com/article/4465154-ocugen-approval-for-covaxin-red-herring-for-investors","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168874793","content_text":"Summary\n\nOcugen missed the opportunity to grab an Emergency Use Authorization for Covaxin in the US earlier this year, but it could still gain an approval via a pivotal immuno-bridging study.\nMeanwhile, Bharat has received WHO approval for Emergency Use Listing, meaning the vaccine can be distributed around the world - but that doesn't directly benefit Ocugen.\nThere are numerous possibilities in play, and Ocugen has no shortage of backers and shorts - the stock is up >4,000% in the past year, but has trodden water for several months.\nIt's hard to determine what may be in store next for Ocugen shareholders, but if I were one, I'd be holding and hoping. I recap the full story below.\n\nKlaus Vedfelt/DigitalVision via Getty Images\nInvestment Thesis\nBharat Biotech received an approval from the World Health Organization (\"WHO\") today to join the Emergency Use List (\"EUL\") for vaccines against COVID-19.\nAs most investors will know, Ocugen (OCGN) holds the rights to distribute Covaxin in the US on behalf of Bharat, in exchange for a 45% share of all profits. It also has a similar deal in place for Canada, standing to earn 55% of all profits.\nOcugen investors and shorts will be nervously waiting to see how today's news affects the biotech's share price, which initially jumped to $16, but has fallen to $12 post-market.\nIn this post I recap the full story, updated from my last post in June, and offer some ways to think about Ocugen's share price in the short and long term.\nOcugen Stock Jumps From $0.5 To $16 In 3 Months On Bharat COVID Vaccine Deal - The Story So Far\nOcugen is one of the more bizarre biotech stories of 2021. In mid-December 2020, its shares were trading <$0.5, as the company struggled to develop a preclinical portfolio of gene therapy drug candidates targeting eye disease, having abandoned development of its lead candidate OCU300 in Graft vs Host Disease (\"GvHD\").\nA delisting from the Nasdaq looked a likely outcome for the company, but then Ocugen's fortunes changed dramatically - the biotech became a partner of Bharat Biotech, developer of the whole-virion inactivated vaccine candidate Covaxin, agreeing to help the Indian Pharma commercialise Covaxin in the US and Canada. Overnight, Ocugen's share price jumped to a price of $3, and by early February, it was trading at $16.\nI covered the full story in a note on Ocugen back in June, when Ocugen's shares were trading in a slightly more down-to-earth range of $6 - $10. At that time, the key question was whether Covaxin would receive an Emergency Use Authorization (\"EUA\") from the FDA, allowing it to be marketed and sold in the US.\nUnfortunately for Ocugen investors, delays in Bharat's trials of Covaxin in India, where outbreaks of COVID had suddenly become widespread, meant that Ocugen could not get positive Phase 3 trial data in front of the FDA in time for a deadline imposed by the US government - after which it would not accept any further EUA requests for COVID-19 vaccines for the remainder of the pandemic for those companies that have not already begun discussions with the FDA.\nOcugen And Bharat Stay The Course - Trials Reveal Strong Efficacy\nThe bad news about an EUA in the US did not deter Ocugen, Bharat, or Ocugen's investors, however. Despite heavy short interest, as many market watchers concluded Ocugen's share price would be decimated without an EUA for Covaxin in the US, Ocugen management felt that there were other options on the table, including obtaining an EUA in Canada, which falls under its agreement with Bharat, allowing Ocugen to earn 45% of all revenues earned in the region.\nThe results of Bharat's ~@5k patient Phase 3 trial in India also came out positive.\nSummary of results of Bharat Biotech Phase 3 trial of Covaxin. Source: Ocugen Corporate Presentation.\nAs we can see above, Bharat's Covaxin (finally) delivered an efficacy readout of 77.8%, 93.4% efficacy against severe disease - and 65.2% efficacy against the delta variant - the most devastating of all the COVID strains. Furthermore, the National Institute of Allergies and Infectious Diseases advised that a novel vaccine adjuvant developed in Kansas, US with NIAID support, Alhydroxiquim-II, enhanced the overall efficacy of Covaxin.\nBharat Pursues WHO Emergency Use Listing Whilst Ocugen Looks To Canada\nThese results, as strong as they are - and it should be noted the efficacy of Pfizer (PFE) and BioNTech's (BNTX) messenger-RNA Comirnaty vaccine against the Delta variant has dropped as low as 39% in studies in Israel - they arrived too late to help Ocugen secure an EUA in the US.\nOcugen turned its attention to Canada,announcing a rolling submission to Health Canada on July 15 through its affiliate, Vaccigen, Ltd,allowing for it to submit new data as and when it came in, accelerating the overall review process.\nIf approved, Ocugen will earn 55% of all profits earned from the vaccine, but as I discussed in my last note when providing some discounted cash flow analysis based on optimistic and pessimistic scenarios, it's doubtful if the Canadian government's purchases alone would provide a significant boot to Ocugen's current market cap valuation of $2.5bn, or its share price of $12.7.\nThe US is the key for Ocugen, and management has by no means given up on this opportunity. In late October, Ocugen made an Investigational New Drug (\"IND\") submission to the FDA. Ocugen's plan is to initiate a Phase 3 \"immuno-bridging study,\" enrolling several hundred healthy adults in the U.S, who will receive 2 doses of Covaxin or placebo, 28 days apart. The endpoints are described by management (in an October 27th press release) as follows:\n\n The primary endpoint will compare blood-based samples taken from U.S. participants who received COVAXIN™ with samples of the participants in the Phase 3 efficacy trial conducted in India. The secondary endpoint involves testing the vaccine's immunogenic profile. The study will also evaluate safety and tolerability in the U.S. population.\n\nOcugen hopes to have the study complete before the end of H122, if it is approved by the FDA, which has yet to make a decision. If the FDA does give the green light, then the US market - and Ocugen's 45% of all profits - is suddenly back on the table.\nMeanwhile, Bharat Biotech received notification today that the World Health Organization has approved its application for an Emergency Use Listing (\"EUL\"), meaning Covaxin will now likely be accepted by a host of foreign governments, and that Indians who have received the vaccine will have fewer problems traveling overseas.\nIt's great news for Bharat, who join the likes of Pfizer / BioNTech, Johnson & Johnson (JNJ), SinoPharm, Moderna (MRNA) and AstraZeneca (AZN) on the list of EUL-approved vaccine developers - but it is not necessarily great news for Ocugen.\nVaccines on the EUL list are permitted to be sent to government's around the world as part of the COVAX scheme, designed to create equitable vaccine distribution around the world, including poorer countries, but the US is a donor to this scheme, not a beneficiary, meaning that Ocugen effectively gets no benefit, and no revenues, as a result of the WHO approval for Covaxin.\nOcugen Stock Is Already On A Downtrend - All Eyes Will Now Be On Health Canada And The FDA\nOcugen stock bounced from a price of ~$9, to a peak of ~$16 in trading today, however the share price quickly began to decline, and finished at a price of $12.7. Post-market, shares were down another 10%.\nThat reflects the fact that the WHO approval for Covaxin does little to improve Ocugen's own fortunes, and in all honesty, was something of a red herring.\nOcugen investors, and Ocugen shorts, are desperate to know what the future holds for Covaxin in the US and Canada, but they will have to wait until Health Canada and the FDA rule respectively on an Emergency Use Authorization, and an approval to begin a drastically reduced pivotal trial in the US.\nIronically, despite all of the news flow and the publication of Covaxin Phase 3 trial data, and the EUA granted to Covaxin by the Indian government, Ocugen's fortunes are in a similar place to where they were when I last covered the company - barring the US EUA opportunity.\nThat opportunity - the one that may have sent Ocugen shares through the roof - has gone, but as I argued in my last post, I think it's possible that the US would not object to stockpiling some of the Covaxin shot, which has a differentiated mechanism of action, and a shelf life of up to years if stored at 2- 8 degrees centigrade.\nCovaxin may have benefits that other vaccines do not, the reasoning may go, such as its ability to induce a Th1 response, conferring cell-mediated immunity and offering durable protection, and enhanced protection against COVID variants, which is the primary concern at the present time.\nOn the other hand, the US may now be able to obtain supply directly from Bharat via the WHO and be in a position to cut Ocugen - the middleman - out of any deal.\nThe fact of the matter is that Ocugen's opportunity with Bharat and Covaxin has always appeared to be one that required expediency of execution, in order to capitalize on a US market opportunity that's uncertain, perhaps negligible, at worst, and a potential multi-billion opportunity at best.\nNobody knows even if Ocugen will get an opportunity to market Covaxin in the US, but if it does, it will need to negotiate a tricky Phase 3 trial first, which could take us into the latter half of next year. Equally, no-one yet knows if Health Canada will approve the vaccine.\nConclusion\nTo summarise the current state of affairs, I would lean toward an approval in Canada - if Covaxin is good enough for the WHO, why would it not be good enough for Canada?\nBut how much product will Canada buy? Probably enough to create a substantial price spike for Ocugen stock, although demand is unlikely to be high enough to sustain that spike long term.\nHow much would the US buy if Covaxin was approved in the US? Again, I cannot see it being a high enough volume to catapult Ocugen's market cap above say $10bn, but if it buys any at all, Ocugen's market valuation is more or less guaranteed to surge, at least temporarily.\nIn conclusion, I would argue that there is enough intrigue and opportunity in the Ocugen story to keep investors interested - on both the short and long sides. The WHO approval does not directly benefit Ocugen revenues wise, but it's another win for Covaxin, which is in turn a win for Ocugen.\nIf I has been holding Ocugen stock since December last year, when it traded at >$0.5, frankly I would have sold by now, but if I had opened a position at ~$10, in expectation of doubling my money on a US approval, I would still be (nervously) holding.","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":824,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690069678,"gmtCreate":1639614219904,"gmtModify":1639614219904,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"[Smile] [Smile] ","listText":"[Smile] [Smile] ","text":"[Smile] [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690069678","repostId":"1194155872","repostType":4,"repost":{"id":"1194155872","kind":"news","pubTimestamp":1639613035,"share":"https://www.laohunote.com/m/news/1194155872?lang=zh_CN&edition=full","pubTime":"2021-12-16 08:03","market":"us","language":"en","title":"Rebound Anticipated For Singapore Stock Market<blockquote>新加坡股市有望反弹</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1194155872","media":"RTTNews","summary":"The Singapore stock market headed south again on Wednesday, one session after ending the two-day sli","content":"<p>The Singapore stock market headed south again on Wednesday, one session after ending the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just beneath the 3,115-point plateau although it figures to bounce higher again on Thursday.</p><p><blockquote>新加坡股市周三再次走低,此前一个交易日结束了连续两天下跌超过20点或0.7%的下跌。海峡时报指数目前略低于 3,115 点的平台位,但预计周四将再次反弹。</blockquote></p><p> The global forecast for the Asian markets is upbeat following results of the FOMC's monetary policy meeting. The European and U.S. markets were solidly higher and the Asian bourses figure to open in similar fashion.</p><p><blockquote>FOMC货币政策会议结果公布后,亚洲市场的全球前景乐观。欧洲和美国市场稳步走高,亚洲股市也将以类似的方式开盘。</blockquote></p><p> The STI finished modestly lower on Wednesday following losses from the properties and industrials, while the financials were mixed.</p><p><blockquote>由于房地产和工业股下跌,STI 周三小幅收低,而金融股涨跌互现。</blockquote></p><p> For the day, the index slid 6.21 points or 0.20 percent to finish at 3,114.88 after trading between 3,106.63 and 3,120.55. Volume was 883.4 million shares worth 761.8 million Singapore dollars. There were 264 decliners and 180 gainers.</p><p><blockquote>当天,该指数在3,106.63至3,120.55之间交易后,下跌6.21点或0.20%,收于3,114.88点。成交量为8.834亿股,价值7.618亿新加坡元。下跌的有264家,上涨的有180家。</blockquote></p><p> Among the actives, Ascendas REIT lost 0.34 percent, while CapitaLand Integrated Commercial Trust retreated 0.50 percent, City Developments sank 0.42 percent, Comfort DelGro jumped 1.45 percent, Dairy Farm International plummeted 2.42 percent, DBS Group rose 0.19 percent, Genting Singapore surrendered 0.64 percent, Keppel Corp shed 0.39 percent, Mapletree Commercial Trust plunged 0.98 percent, Mapletree Logistics Trust declined 0.53 percent, Oversea-Chinese Banking Corporation fell 0.27 percent, SembCorp Industries skidded 0.51 percent, Singapore Airlines dipped 0.20 percent, Singapore Exchange slid 0.21 percent, SingTel dropped 0.41 percent, Thai Beverage tumbled 0.75 percent, United Overseas Bank collected 0.15 percent, Wilmar International tanked 0.96 percent and Yangzijiang Shipbuilding, Singapore Press Holdings, Singapore Technologies Engineering and SATS were unchanged.</p><p><blockquote>资产中,Ascendas REIT下跌0.34%,凯德综合商业信托下跌0.50%,City Developments下跌0.42%,Comfort DelGro上涨1.45%,Dairy Farm International暴跌2.42%,星展集团上涨0.19%,云顶新加坡投降0.64%,吉宝集团下跌0.39%,丰树商业信托暴跌0.98%,丰树物流信托下跌0.53%,华侨银行下跌0.27%,胜科实业下跌0.51%,新加坡航空下跌0.20%,新加坡交易所下跌0.21%,新加坡电信下跌0.41%,泰国饮料下跌0.75%,大华银行上涨0.15%,丰益国际下跌0.96%,扬子江造船、新加坡报业控股、新加坡</blockquote></p><p> The lead from Wall Street is broadly positive as the major averages opened slightly lower on Wednesday but then surged in the afternoon to finish sharply higher.</p><p><blockquote>华尔街的领先优势总体上是积极的,因为主要股指周三开盘小幅走低,但随后在下午飙升,收盘大幅走高。</blockquote></p><p> The Dow soared 383.25 points or 1.08 percent to finish at 35,927.43, while the NASDAQ spiked 327.94 points or 2.15 percent to end at 15,565.58 and the S&P 500 jumped 75.76 points or 1.63 percent to close at 4,709.85.</p><p><blockquote>道琼斯指数飙升383.25点或1.08%,收于35927.43点,而纳斯达克指数飙升327.94点或2.15%,收于15565.58点,标普500指数上涨75.76点或1.63%,收于4709.85点。</blockquote></p><p> The late-day rally on Wall Street came after the Fed announced its widely expected decision to accelerate the pace of reductions to its asset purchases program. Citing inflation developments and further improvement in the labor market, the Fed said it has decided to reduce the monthly pace of its net asset purchases by $30 billion per month, double the previously announced $15 billion per month.</p><p><blockquote>华尔街尾盘上涨之前,美联储宣布了人们普遍预期的加快资产购买计划削减步伐的决定。美联储以通胀发展和劳动力市场进一步改善为由表示,已决定将每月净资产购买速度降低 300 亿美元,是此前宣布的每月 150 亿美元的两倍。</blockquote></p><p> The Fed said it expects similar reductions in the pace of net asset purchases will likely be appropriate each month, pointing to an end to the program next March. Analysts partly attributed the subsequent rally to relief that the Fed was not more aggressive in accelerating the timetable for halting its asset purchases.</p><p><blockquote>美联储表示,预计每月净资产购买步伐的类似降低可能是合适的,这表明该计划将于明年 3 月结束。分析师将随后的反弹部分归因于美联储没有更积极地加快停止资产购买的时间表,这让人松了一口气。</blockquote></p><p> Meanwhile, the Fed also announced its widely expected decision to keep the target range for the federal funds rate at zero to 0.25 percent. The central bank's latest projections forecast as many three rate hikes in 2022 compared to the lone rate hike forecast in September.</p><p><blockquote>与此同时,美联储还宣布了广泛预期的决定,将联邦基金利率目标区间维持在零至0.25%。与 9 月份的唯一一次加息预测相比,央行最新预测 2022 年将加息三次。</blockquote></p><p> Despite the prospect of sooner than expected rate hikes, analysts suggested traders were pleased with the increased level of certainty provided by the Fed's latest projections.</p><p><blockquote>尽管加息前景早于预期,但分析师表示,交易员对美联储最新预测提供的确定性水平的提高感到满意。</blockquote></p><p> Crude oil futures settled higher on Wednesday after the Energy Information Administration (EIA) said crude inventories in the U.S. dropped by 4.6 million barrels last week. West Texas Intermediate crude oil futures for January ended up by $0.14 or 0.2 percent at $70.87 a barrel.</p><p><blockquote>美国能源信息署 (EIA) 表示上周美国原油库存下降 460 万桶后,原油期货周三收高。1月份西德克萨斯中质原油期货收盘上涨0.14美元,或0.2%,至每桶70.87美元。</blockquote></p><p></p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rebound Anticipated For Singapore Stock Market<blockquote>新加坡股市有望反弹</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRebound Anticipated For Singapore Stock Market<blockquote>新加坡股市有望反弹</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">RTTNews</strong><span class=\"h-time small\">2021-12-16 08:03</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Singapore stock market headed south again on Wednesday, one session after ending the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just beneath the 3,115-point plateau although it figures to bounce higher again on Thursday.</p><p><blockquote>新加坡股市周三再次走低,此前一个交易日结束了连续两天下跌超过20点或0.7%的下跌。海峡时报指数目前略低于 3,115 点的平台位,但预计周四将再次反弹。</blockquote></p><p> The global forecast for the Asian markets is upbeat following results of the FOMC's monetary policy meeting. The European and U.S. markets were solidly higher and the Asian bourses figure to open in similar fashion.</p><p><blockquote>FOMC货币政策会议结果公布后,亚洲市场的全球前景乐观。欧洲和美国市场稳步走高,亚洲股市也将以类似的方式开盘。</blockquote></p><p> The STI finished modestly lower on Wednesday following losses from the properties and industrials, while the financials were mixed.</p><p><blockquote>由于房地产和工业股下跌,STI 周三小幅收低,而金融股涨跌互现。</blockquote></p><p> For the day, the index slid 6.21 points or 0.20 percent to finish at 3,114.88 after trading between 3,106.63 and 3,120.55. Volume was 883.4 million shares worth 761.8 million Singapore dollars. There were 264 decliners and 180 gainers.</p><p><blockquote>当天,该指数在3,106.63至3,120.55之间交易后,下跌6.21点或0.20%,收于3,114.88点。成交量为8.834亿股,价值7.618亿新加坡元。下跌的有264家,上涨的有180家。</blockquote></p><p> Among the actives, Ascendas REIT lost 0.34 percent, while CapitaLand Integrated Commercial Trust retreated 0.50 percent, City Developments sank 0.42 percent, Comfort DelGro jumped 1.45 percent, Dairy Farm International plummeted 2.42 percent, DBS Group rose 0.19 percent, Genting Singapore surrendered 0.64 percent, Keppel Corp shed 0.39 percent, Mapletree Commercial Trust plunged 0.98 percent, Mapletree Logistics Trust declined 0.53 percent, Oversea-Chinese Banking Corporation fell 0.27 percent, SembCorp Industries skidded 0.51 percent, Singapore Airlines dipped 0.20 percent, Singapore Exchange slid 0.21 percent, SingTel dropped 0.41 percent, Thai Beverage tumbled 0.75 percent, United Overseas Bank collected 0.15 percent, Wilmar International tanked 0.96 percent and Yangzijiang Shipbuilding, Singapore Press Holdings, Singapore Technologies Engineering and SATS were unchanged.</p><p><blockquote>资产中,Ascendas REIT下跌0.34%,凯德综合商业信托下跌0.50%,City Developments下跌0.42%,Comfort DelGro上涨1.45%,Dairy Farm International暴跌2.42%,星展集团上涨0.19%,云顶新加坡投降0.64%,吉宝集团下跌0.39%,丰树商业信托暴跌0.98%,丰树物流信托下跌0.53%,华侨银行下跌0.27%,胜科实业下跌0.51%,新加坡航空下跌0.20%,新加坡交易所下跌0.21%,新加坡电信下跌0.41%,泰国饮料下跌0.75%,大华银行上涨0.15%,丰益国际下跌0.96%,扬子江造船、新加坡报业控股、新加坡</blockquote></p><p> The lead from Wall Street is broadly positive as the major averages opened slightly lower on Wednesday but then surged in the afternoon to finish sharply higher.</p><p><blockquote>华尔街的领先优势总体上是积极的,因为主要股指周三开盘小幅走低,但随后在下午飙升,收盘大幅走高。</blockquote></p><p> The Dow soared 383.25 points or 1.08 percent to finish at 35,927.43, while the NASDAQ spiked 327.94 points or 2.15 percent to end at 15,565.58 and the S&P 500 jumped 75.76 points or 1.63 percent to close at 4,709.85.</p><p><blockquote>道琼斯指数飙升383.25点或1.08%,收于35927.43点,而纳斯达克指数飙升327.94点或2.15%,收于15565.58点,标普500指数上涨75.76点或1.63%,收于4709.85点。</blockquote></p><p> The late-day rally on Wall Street came after the Fed announced its widely expected decision to accelerate the pace of reductions to its asset purchases program. Citing inflation developments and further improvement in the labor market, the Fed said it has decided to reduce the monthly pace of its net asset purchases by $30 billion per month, double the previously announced $15 billion per month.</p><p><blockquote>华尔街尾盘上涨之前,美联储宣布了人们普遍预期的加快资产购买计划削减步伐的决定。美联储以通胀发展和劳动力市场进一步改善为由表示,已决定将每月净资产购买速度降低 300 亿美元,是此前宣布的每月 150 亿美元的两倍。</blockquote></p><p> The Fed said it expects similar reductions in the pace of net asset purchases will likely be appropriate each month, pointing to an end to the program next March. Analysts partly attributed the subsequent rally to relief that the Fed was not more aggressive in accelerating the timetable for halting its asset purchases.</p><p><blockquote>美联储表示,预计每月净资产购买步伐的类似降低可能是合适的,这表明该计划将于明年 3 月结束。分析师将随后的反弹部分归因于美联储没有更积极地加快停止资产购买的时间表,这让人松了一口气。</blockquote></p><p> Meanwhile, the Fed also announced its widely expected decision to keep the target range for the federal funds rate at zero to 0.25 percent. The central bank's latest projections forecast as many three rate hikes in 2022 compared to the lone rate hike forecast in September.</p><p><blockquote>与此同时,美联储还宣布了广泛预期的决定,将联邦基金利率目标区间维持在零至0.25%。与 9 月份的唯一一次加息预测相比,央行最新预测 2022 年将加息三次。</blockquote></p><p> Despite the prospect of sooner than expected rate hikes, analysts suggested traders were pleased with the increased level of certainty provided by the Fed's latest projections.</p><p><blockquote>尽管加息前景早于预期,但分析师表示,交易员对美联储最新预测提供的确定性水平的提高感到满意。</blockquote></p><p> Crude oil futures settled higher on Wednesday after the Energy Information Administration (EIA) said crude inventories in the U.S. dropped by 4.6 million barrels last week. West Texas Intermediate crude oil futures for January ended up by $0.14 or 0.2 percent at $70.87 a barrel.</p><p><blockquote>美国能源信息署 (EIA) 表示上周美国原油库存下降 460 万桶后,原油期货周三收高。1月份西德克萨斯中质原油期货收盘上涨0.14美元,或0.2%,至每桶70.87美元。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.rttnews.com/3249611/rebound-anticipated-for-singapore-stock-market.aspx\">RTTNews</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3249611/rebound-anticipated-for-singapore-stock-market.aspx","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194155872","content_text":"The Singapore stock market headed south again on Wednesday, one session after ending the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just beneath the 3,115-point plateau although it figures to bounce higher again on Thursday.\nThe global forecast for the Asian markets is upbeat following results of the FOMC's monetary policy meeting. The European and U.S. markets were solidly higher and the Asian bourses figure to open in similar fashion.\nThe STI finished modestly lower on Wednesday following losses from the properties and industrials, while the financials were mixed.\nFor the day, the index slid 6.21 points or 0.20 percent to finish at 3,114.88 after trading between 3,106.63 and 3,120.55. Volume was 883.4 million shares worth 761.8 million Singapore dollars. There were 264 decliners and 180 gainers.\nAmong the actives, Ascendas REIT lost 0.34 percent, while CapitaLand Integrated Commercial Trust retreated 0.50 percent, City Developments sank 0.42 percent, Comfort DelGro jumped 1.45 percent, Dairy Farm International plummeted 2.42 percent, DBS Group rose 0.19 percent, Genting Singapore surrendered 0.64 percent, Keppel Corp shed 0.39 percent, Mapletree Commercial Trust plunged 0.98 percent, Mapletree Logistics Trust declined 0.53 percent, Oversea-Chinese Banking Corporation fell 0.27 percent, SembCorp Industries skidded 0.51 percent, Singapore Airlines dipped 0.20 percent, Singapore Exchange slid 0.21 percent, SingTel dropped 0.41 percent, Thai Beverage tumbled 0.75 percent, United Overseas Bank collected 0.15 percent, Wilmar International tanked 0.96 percent and Yangzijiang Shipbuilding, Singapore Press Holdings, Singapore Technologies Engineering and SATS were unchanged.\nThe lead from Wall Street is broadly positive as the major averages opened slightly lower on Wednesday but then surged in the afternoon to finish sharply higher.\nThe Dow soared 383.25 points or 1.08 percent to finish at 35,927.43, while the NASDAQ spiked 327.94 points or 2.15 percent to end at 15,565.58 and the S&P 500 jumped 75.76 points or 1.63 percent to close at 4,709.85.\nThe late-day rally on Wall Street came after the Fed announced its widely expected decision to accelerate the pace of reductions to its asset purchases program. Citing inflation developments and further improvement in the labor market, the Fed said it has decided to reduce the monthly pace of its net asset purchases by $30 billion per month, double the previously announced $15 billion per month.\nThe Fed said it expects similar reductions in the pace of net asset purchases will likely be appropriate each month, pointing to an end to the program next March. Analysts partly attributed the subsequent rally to relief that the Fed was not more aggressive in accelerating the timetable for halting its asset purchases.\nMeanwhile, the Fed also announced its widely expected decision to keep the target range for the federal funds rate at zero to 0.25 percent. The central bank's latest projections forecast as many three rate hikes in 2022 compared to the lone rate hike forecast in September.\nDespite the prospect of sooner than expected rate hikes, analysts suggested traders were pleased with the increased level of certainty provided by the Fed's latest projections.\nCrude oil futures settled higher on Wednesday after the Energy Information Administration (EIA) said crude inventories in the U.S. dropped by 4.6 million barrels last week. West Texas Intermediate crude oil futures for January ended up by $0.14 or 0.2 percent at $70.87 a barrel.","news_type":1,"symbols_score_info":{"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":5184,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872766499,"gmtCreate":1637576322119,"gmtModify":1637576322119,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/872766499","repostId":"2185826772","repostType":4,"isVote":1,"tweetType":1,"viewCount":1318,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847697615,"gmtCreate":1636511453772,"gmtModify":1636511453902,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"okay ","listText":"okay ","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847697615","repostId":"1179672442","repostType":4,"isVote":1,"tweetType":1,"viewCount":956,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871759657,"gmtCreate":1637115093499,"gmtModify":1637115101793,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"title":"","htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871759657","repostId":"1185179037","repostType":4,"isVote":1,"tweetType":1,"viewCount":1265,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}